var title_f10_54_11104="Three finger rotation from occiput posterior";
var content_f10_54_11104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Three finger digital rotation from occiput posterior",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 647px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The tips of the index and middle fingers are placed in the anterior segment of the lambdoidal suture near the posterior fontanelle. The fingers are used to flex and slightly dislodge the vertex, rotating the fetal head to the occiput anterior position via rotation of the operator's hand and forearm. The thumb may also be used with gentle downward pressure more anteriorly on the parietal bone to aid in this rotation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11104=[""].join("\n");
var outline_f10_54_11104=null;
var title_f10_54_11105="Almitrine: International drug information";
var content_f10_54_11105=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Almitrine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Sovarel (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1977641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Almitrine Dimesylate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1977643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Respiratory Stimulant",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1977646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory stimulant used in acute respiratory failure such as chronic obstructive pulmonary disease (COPD)",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1977642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Oral: 50-100 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     I.V.: 1-3 mg/kg/day in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1977645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Injection, powder for reconstitution: 15 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet, as dimesylate: 50 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10510 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-E2FE460E4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11105=[""].join("\n");
var outline_f10_54_11105=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304140\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977641\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977643\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977646\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977642\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821058\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977645\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10510\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10510|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_54_11106="Clostridial myonecrosis computed tomography";
var content_f10_54_11106=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 612px\">",
"   <div class=\"ttl\">",
"    Clostridial myonecrosis computed tomography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 592px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Necrotizing fasciitis due to Clostridium septicum. Air is demonstrated in the external iliac vein, with air fluid level (Arrow A). Gas in the soft tissue of the buttock is also seen (Arrow B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Mann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11106=[""].join("\n");
var outline_f10_54_11106=null;
var title_f10_54_11107="Sellar mass MRI I";
var content_f10_54_11107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Sellar masses",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 199px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The unenhanced MRI on the left shows in sagittal view a clinically nonfunctioning pituitary adenoma that is extending just above the sella (arrow). The unenhanced MRI on the right shows a sellar mass of similar size (arrow), which is interpreted radiologically as a pituitary adenoma, but pathologically was found to be lymphocytic hypophysitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter J Snyder, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11107=[""].join("\n");
var outline_f10_54_11107=null;
var title_f10_54_11108="Isoelectric focusing Hgb variants";
var content_f10_54_11108=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F63606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F63606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Isoelectric focusing for various hemoglobin mutations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 724px; background-image: url(data:image/gif;base64,R0lGODlhTwLUAvcAAP///wAAABoYGERERLu7u4iIiCIiIt3d3ZmZmWZmZjMzM8zMzBERERkYGO7u7lVVVRoYGf///v7+/gEAAP/+/hoZGXd3dxsZGaqqqv7////+/+Dg4GBgYBsYGBAQEPDw8BkXGBoYFyAgIKCgoBoXGEBAQDAwMBkXF4CAgNDQ0MDAwBsYGVBQUBoXF7CwsP7//pCQkHBwcP7+/xoZGCwrK/Pz8z49PRgXFxkYGXx7exsZGF5dXc7NzRkYF+bm5v7+/ZmYmC0sLOfm5tra2piXl7Szs/Tz87Ozs/Py8s3NzQEBAT89PT4+Pj09PfPz8hkZGf79/ubl5ZiYmH18fBgYGAABABsZGm1tbV1dXT8+Pl5eXvLy8hwZGZiXmF9dXbOysisrKy0rK83MzIqKisHAwM3MzW5tbbOzsn17fHx6egEBANva2gABAebm5V5cXSwqKrSztPT09KalpU9NTXt6eouKivT08317e87MzT48PE5NTT08PHt7e+bl5sC/v/39/V9eXj49Ps3NzJqZmefm5wIBAf79/SwrLJmXl4qJiaWkpCsqKiwrKufn5ywsLG1sbefl5i0sK6WlpXx8fF1cXF5dXk5OTj48PT8+Pc7OztnY2bS0s05MTNnZ2ZqYmbKysmxsbKamprO0s+jn57SzspeXl4uKi9vb2j4+PZiWlk9OTpeXlqelpXx7fBoaGhsXGHx6e25sbVxcXOjo6PPy83x7eisqK5iYl/3+//3//3t7evPz9E1NTQEAAaWmpRwYGPTz9Nzb2xgXGC0rLNrZ2drZ2qalpujm5316exwaGv3+/vX09OXl5V5cXGBeXkA+Pj49PJmYmT89Ps7OzSwqK318e21tbF5dXBsaGi4rK11cXbOys3t8e5mYl9vb2ysrKk5NTOfl5bS0tOjm5hsXF25tbIyLjBoZGsLAwPX19UA+P+bn511dXMDAv21sbAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABPAtQCAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3r9+/gAMLHky4sOHDiBMrXsy4sePHMBUEsPAwQYABDDEEYHAAsufPWw0ECLAAo2TKDTUbcNCwQAAFoGPLjqp5NGqLpx0OCFDA4IMArAuKxjC7uPGjlhkEMDBQ+YPdBkoDQCD6svQFkg2IRl1AeYAHwQce/9h88Hf4ga4THF/P3qdy1wEICHQO4Ddz1Q4IbHbgQDkCALm5htlvDxSkGWa+AWeQfsy15+CDMyFA3m7qAaAcZa4xAACFAolWgIQaAjiZhQEQB2JB6REk2WgskiYeeRDGKKNKuxV4IokYkpebiBZY8JpApznQIovnpZjgeQKNF+KMTDb5UX9DlogjABluGECFHrrWYG7+JXRgeQoWxKCTZJaJUZUC1Thllfgx6MACoxHgwHYA+KgAaxgg+OKSBJlnkJFmBipoQ5IVKFCGUOYYInWjDSCdhK/RSWV1Ixa0W28ODTfoppzahF9rP3Yq6qguWaanl5t1RuqqrLbq6quwxv8q66y01uoXmlNS5ICPo2Fq66+d4nqhrqL9B+yxZCo3gHIKdCZspRJZViGy1M6onHqWwfbsbQOt2CJswl02mgLSVWvueu8BUNsB8A3J7UNCBvCfZQ2ea+9s6da2wLYTxfsfnC7eK/Bn6Z7Ib0HesgguQR4CALCqA0fcWLpqHiyRawVmK/HGjDE7mqEWR7SAAd6Bx/HJiKXr4AC+VqSZsRm5Vq5ADihgKMro8ibbAHrqJx/LCfk8EM8HGYBpu5chmVB8Az0wLUEHMAAzzlR7RbRAQgONkNBpnioQAgwE55pAcL67tHwACAkxivVW7bZWVwOQ9QCiRScm0137dtvYHar/p99oBqB9pXcsTuvAbq9dF/DbjFsVd9bk1te23Hhv6LWFxB0aANaVC/QAuJep2nmdsDnwAMxSN646VYi3+DOmcK79d4uXV460AlNTLlDlo1vQrEFary58TiNEafxoJRD0ONNaj4c258/HPZDtm2t+gAMJEL7786MfgPgAEAc//PgyfcCBBylMtPzrZIcJ/dCXM5A5ldUDMB4CCSggn37bT/98QQcwwG1SR74CvmQDJjDBByiyvg0ZCgFe45rl9Iae+lnmAM/xXPUqx4CW1QdTCoDd4gxIQpSowAMxsEgD6TYuJElQel8Lm+YUJp+RfWyDz4PUtLrzMfRMroRAFAkK/zwwAp0YrSRRy10Ql8iRD7BABOnTyctGUrObSex4UWKiSVJgAhYsUItaqR8YQeICD6BgjFsRIxo5EgMPuIBq4gsKAX44EjWuESMfKIEJNjCwFXqQIN1pzsLk1xD+gWSOKbHjHSuSAhFw4IsC82NC4FSa8SgITko7iCE/gkiUKHKREikeDDa2QhbarSAdVJcCCFmA0n2PNdhpVLxGg4ACGGBFBUAc7FaEmtbdjFfaSSQoL3I+FXBshZF7wA8fUKAePaA3D6DMAO5UM/UogDLYOcAmu/Mf11BGM/xhgHoWQMD2EceWzqKjSD45TIYgUIEnax2L2OewAKyNShpSAAYKAP+eEgnpUcxRwKm2iSBDCokAGFhSAp62od6EEGvqDAk76yIBAFQUABkYyAs2ilGBZHSjFc2oRUd6UYVkQKQKqahKPWpRjor0oxxlKUxOyAGcSdJ+o4OTft4kP+DMDnByW5Hf6pdLzvkPaVeaTut6g7dOnmSicqGAQKQqEapmVKpUpepUGaJVAGTVqx0F609gQEQ49ox5IlQaA6aZtsuUzn13wwBBjbo9DCwsSUltKAACB1Fh4kWkFbhBBRpQAQ14NQICGOwMGtAAgjBWABeAwEB+kFjCCtajjxUABBp7UgA0AAICEABjAStYwgrgBwOBwAVE29iBMHaxFRBABKRq2JX/mA+KL4mjSPRzTwndUy0rfODl6lOpHWkNfwD6T9QIoNNDFbR+8emPdApQgObOsTcJ6M3hIgoSqL5ltpANrQAIcoIOiLcCWY0tFyAbgfYCYAbiXS0FIgCA0K42tPQFAGLtG1r9UiC8oZ2Bftu72vWid6qxDW0HTvASLpYAkiS56UGUpKqFHkSeZhsIbwEwuressDp3OohrMuejzNVsNKm0TK8EouJaPtd/DgOxfFSsgCOe+Dvc/Yh34RLf8U71vgJYMHk7QGQfe5W//RWIeYNMgvF2VgAkWHIHBtJjAWg1yERm8EDKG9+uGk8kZTwjSiRsECVVyMLAQ9CIt2ZPDv9v/5E7ZstVIQuBE1RAIPQ9wQq6/OPQgnakALhABU6gWitjtMniNXJ9E02COUfWzhcQSEU1a9+sAnkFDM7vQeI8kSG+MSWlrNvMcOqazqDZUgi6H/3G1Rneti4BGxbXa3hoAFXBh68czp68YgmtgXF6LYZlbAMu0IOBaCC2DRAvQUJbgWZvtQE9uICwAWDYC9iZsTggCA4YO+hIB5uxxG4sVZud4GWHNtmFVcivH5JHE0QR1Gf9WTInN54AYouhecPneeZEmVijLdYDCGfkrjkdpnWHNaFLmzgdVk6Brbsuhu1qQmSgkNoyxOIHoThXqc2QhzOkkV5kiTzjpNd6rq3emv85wKmV16IHjLqo/uZcZ/CmNQsM6Gapw1tCB7Lye3n8XD9PyAg8MEqMpACLUUoe/DSMVrz+r94OtHC7/hM3ujlMxZeh3Mz/3WaaHw0zA5gW0PCGVHxPRbcYQTtECmB2mAS9Wm83SDEzsoGySuSmmIRamxlk9rj51gDgoxJmYq51N6fp6/XB+X90fteokNkgLWo4ivSk9oew/SZxR1bmBfKBBPIRjyaoqfri7cCveQ3qVuo7gmrGnFQeQKCFT2Xhve7cgsvn4IZX+HT/qJTHF0RnxM2k4IfG+7W3/SWbB9bmU+AB0WeEBUofPdN/BmIkoV4/faddZyB1y8G3WYeE11r/UVeN68rZ8DVvXkqolzNqDmPKt2l75U+9N83NPEo5BORV6g4HOPW063fItzqZBwMBUEQagQLwdCzIVBrKBHmYcjXTxB8K4H+Upz+JRzn/4VsJ5SzqcTVOQxD85nYCaBG39W4YMXQm+Csj13Qm93stkgD8ETDUMXyH9zXMYQE3YwAIkFDP80+HwlDj5xLJ9ytBh0APthHMZ0zUclPO83uYYm8/tRw0WHIzOHLzMi4EsE3jhHXD5VeN83NllEIb8QFEZy54B1fux3OrgYZBeFw3mGFp0ixEpR6A5yxd6EkjKBFDZIAbEXrnElym54BkYwAd+H7+J0NUyBwEECKmQwBs/8caNrdXpYEd6uF6sBeAqrNuTuRuHcEBJmAvH9ZCkPeCNLMiqXRj3vN+DQIpoUMAK/I7NgR46sF9lyiEeegQIAdhGQEDIqCL7eQUQ2grnDZ0YsYRZZSCvwiMt7gQbaSEHMF8fJiMUBGMteJd7fZ5TWQCxSiN07iMB8F8j/QRJeB83NiNmYh0oxGNHOGJvnhMxacQlXcSEKQ+HqRqHDYvP0SNtKKPDjF02BhJpBePvPYdnRGPF9EfMGNLBzGPd/eOHScxJbU0K6ECAYCMoBiQ79gfBTUA9AQSuNeEBsGQEWGQ6tYXUOAUGLdpKlF36giQ02c5onY37cczksEA0wU4t/8HLjYzH3LFIriGMB1YIL4UiACQP+ySatWjf1RXfza5OwjwN92UjziTkruTEp0nhqQUkPNWEEKCO5Zigcxke/qGSUKiIXnXNI3HOdmzNnBiIphhAbVGg+OhLpxBJR0IloYiLx0SlZAXMStVkijBAiwAEejIItHHKStIT7EjJt7SS6p4gfPxH/KTS5PZeJtUEJbxR0ADQehUezhFl//jhk65l5PSl5mIEjGQgA7BjxDChB02ED7SG6IZdsRXHzjIdjhIGdijPbNTIRumVCzSG2ADfHJZPTRGTzN4j6SpkL+nF1SJFLQ1EBFJEKx5ECgYEdW5MhjZPsLXN4kImRYSlTb/mVAGQBz5sz+ftGHjUSGbWZ6yN35zqTywIZrKuVd82Zx4YVggsFn8CQH++Z8AGqACOqAEWqAGeqAEGlmthRDZSRBJKBENyh6AqFQFAUFoIyHEIZoScnsyBCdvpSAZRFxs1hnWdUTzqB/nFDamszmPWCdg95j1qYOliZ948V8L5p+ahaA6uqM82qP+CW34JZEkQYYt2RBDSJJph2+EOBeh+BpIsgBYJ6PfSX7PwwCo8TmDeEMjymLjYqIIsqFWciWb44qsNqV6aZ8zSp15kVGhNQFuOgGFGadyOqd0OhpwOgECAAJhZZoi0XnkSJh3t51LQ3J3ozDtNzQUOEbjMT98/4oXiQWndRqpkjqpSjAaq0VfzxmhnlgRD+d7ANRhQjMnaYmoUxhEf3N8HLYX1lapk9qqrhqnanACFxCdjfoRvNiOqxmoL8kzMVlmoIo3CdAgLfKAsNYi3uN/t9QrupQkKwIyAiWFvBI5JxOhVqEBbcoib5qt2rqt3Nqt3vqt4OqtAVAFAZBsYlWrHXGMFtGpWsmAdASSBCE0AeRBrsEatNmGh9hNIwJOe4UZ84pPR2M3wYoy1GoVkAWpr5qwCjsa5DpoW4WuSOhGF9GpUaKYbfap6fdTR/R7P5OoaeKxBhUflHQozBGED4VTv+U4DtkQ2XUVBUsV1noCCLuwNOuqof81nWr6ER8gAttIEey6q0/YYU3ok5TDdd3kLR07hff6Ytvzm/wThFGSskzhqTgVJX/UslbxslPxXzPQIuH6tWAbtmLrpixiri/AoCDhhxjxs++jNWdJEM11N89DiGCDKczjsRsCstDFXAGjkCbLqKwjqOqmRDy3skyhtVExaQoWZYnWuI77uJAbuZI7uZTbAXuWWIDZiaq5rrratsIlYmhYtF8jL7jnGkmLe3lLg5vENIBnP0cUhPxENqPaFOt3SpBnLMPKYtoFe6/XQ5OCS8sapt+hE4gbFRFAWLJ6bsK2vMzbvM77vNAbvdL7vJo1WAvKYVnUEUOHqxDauaLLQk7/qne0pEmRt7s3lLSouLR0ZXi9O7ylinWo2nvtKjkMmjv1WpQOhSCt+6/cRD/fBFdtmRPFCxUVhVXz9RRnSxInZJE+q4IVW3KLebuQN2O5hCAjW5rjF7JvhqQsMcBQkV/0pWlGEVIoAY0c4cGf4ZrpV5+tNE9FqRxcpypPy7SGB0HBKcB6UVEijBQ4O6QmgJUagcKecYaZpJd12z8JMAASMol9W7I0HB/rWYM4IcROcVE9PBQVpQEap3EhIZgeQcWPMaEi+XvdJEOmi7/41Bn7+7pPzLf7s7GY9495ccVIgVIgkZrcy6kbwcEUsaR80aQhtmn/cWO/QcEsVmvtCzJt/1yUXWq4LREAPWsXdswUnTXJHOGPOua9WfOO47EwY1KO6+oByXh0ztgRbPu9nEyo9gHK62oCRTpGRCpRmsw8pjRq4zEABXLLDcJrGIKIR0SbjLwct4eTcDYCnwhKfrpOsyxv7vqpvpVLA9sf45Q60TQdhkKbFtCU1AWmqItGm+MBpYxGHHCYmTySD+y2F4tXr5fNBDCwO8di6jEn3hMctGmlfaJ4eMHH5Cu1T7E5KPCnYIQCvVhHy1xy8IqyEsIcA1t2MeQrtHmmH1ubbkG1BKEc5dJU6WykK+wTm7MBASDHTHSdBD2Sgvq2KBueRXkfaVkzAaQq9cwtYRmZHia4W//DAHCM0fy8aRvdE9XDAZEcRMz3aSMNEWJ8ehkdzU1JJdDUG+NHm9lTGttscIjYFrV7qBaQAHCZJoWzYUNpOTVZGq82Oz9JvAJxQrAsAkVHEqecNdX3qWszsDGGhaj7yxXyG8JMpXCxgPRrEPJzwTgNt1IyTfIR0x2GpTxRP67MF3/Jw4CGEWpbEmDsGIkJwRlNlx2CGn+tPLIJo7/K0wNhzHMsnQ+x2KKdEThL2gtBxxGxqU+lgoJ60EVZIVmdextmwytGn3izmyzi2QOBPnfxnBfxnCd5EMNdEMC9EmSVx1/s2kDLnag0JPKB01GsV7iNNuepO4dNEP88F8dNEJb/LBHdbRDh3RDfbREL7IW0UtQGwicCZCGYwlslutk2OB+YEqK/wdsC4dHKvRZ/WVLljRBW3NgV0d8QgVKq3RAmjN4Xoc9DHJBt3SdPk80FdyUbRmO/DKM6dH73nd0E4dOAceA3AeLspo0rsdYsiBCMYhusPLEFoQIiMBclFXEEkZK1lZJfRasCbmwC8ZwxDlZfNeM7btwZUQKDWeIFXXn6cTSzu+K5WhAi8Mps8VmRJVmpBVorsFmOBQEVgOUUYFg44J8Kmlqf9Vl6qgH6yZ+f5Vqq5Z/ZpgFS9Vlbfr2ftWf+iRF43MFHXssowifTc8N5J+G2ib0rlmv+kbtjZEcj/0DObkEBQCZgVCYAIRDpM5BVMxACljte7cW1fAYALSAALXABTbZsJHABnd4CfRZgVuZeArACHRACkz5VlR7pSVYRmIznJL2rW0kQmuFyCHG/hCQZpUFIFYRwgQdIoQtEdkSGDIwWCWxfJ6BooRXpIQDtlo65eBZayetjL+DppL5ay9btnd7skPXssjUQsdXq1C7riibodLrskH135yxC92RLgPNHTBNN5DQAFmDShvear1lCihQDAL0W9DXu3k5lUjZeZl5fSwYBhtVezu7tBU9kKxDqVEYCrG5e+lVf1nZf7qUBoBVkCm9YIi/yR2Hi9ATb4lHIVIK0Lc9PCBBC4P/SwiRnOy5PFwxeqjhFuBwBl4eKEO3bduTkyFVpEPotF1I+657VuOYGWXp6wPGF5QIhXvuppwNR9comEEnfX7MFACAAZE1/bid/5GmVEPdzxIbnoQXQlZSB9kyDN26/02NB0SSLYhhyhyGh8vCIGeQEuAORck1uECzw02hBcRSwbZU2UqoFAsjmWImlWQXM8eeGA1IlA5tlvVYvECDAbZ9l+IgfXmAlAaDV+K6VWF8vWZEvFChfehRKEAtVYZxRunijHKwhGSnKGmdMdmb872RB97F5KNqC9yCRxBEh7F6JEMD8kAfh4nAh41vV410u3gOhcVg1EDj+EM7v4wLBxVT/6eYcJ2lEsfrgG8gDYduJkzbNijeGfb+E/PZo0/5yLxZV/al/ZEuIg7vKhTjN8n+qAhAIGAQwEOAAgAMKAgR4AMDhQwAMMDx0MCDAgAQJIEIMQAAAAQYHNz4swGDkSQABUAIQMWLlS5gxZc6kWTOmBocRIEp4yBOlzocZIALF+RDoT4hFjwIQanSlTwBQbU6lGlNlVaxZtW7l2tUrgAEDHhLoCFbBAgAPDGxEEMDByJIFAJR0GAABAAUKHDh44NGhAwMWPpZdYBCAAbEHDMiFWPitw7AIFWg82XEhY5SFRcK8enJEia+hRWstKsPhC5QZmkJczRQiagCmAeDk2Zp1/9TZDmXDdtjaNtPfo4Vv7Dzc+HHkyWNaXNjc4wDGmiEWKE5SLELDdgtPPFlArIWGdQ8URjt3LUSyFAOUL0B5JOHFL8taXfnBQwrl+fXv598fa3X/AhRwwIcic4is5xg7YD6H2npsuusWPMgusjYDYIEEmhMLuocMqvDA6tIDkSSNFlAoAMrmK2AtgRa6q0O/OHspBg4ItPFGHHOcCUAde/QxKwMHS9AhxyBaEDPrHJIwJQS2gwixg7wDIAHBxCPPoRU3KhI7EgFAQLArVVzLgrvoItIw+lbaIIAPfnTzTTiH4zFOOusMEkGwwkPgOogsCIAxBBSYK8Ls7jJAr7RAkv8rIbEEitIwxBCKbyOJHjIALRPdA8CB9VJadFKHMDAJy1HTXIkFFOpUdVVWV5qTKg51TOC8VpO7s6wBCgoAUbgGIkgwKbGb8K6EFlLggLYIUuC6DC8yrFiGTkqAzwUKQkzTAaokaKHwlDSAO7A0lQ8mFUSo9Vx04Xx1pVuHdHWhGMdq7s+agk333tEQoBWmBeMdyYHJYBxpAQZeBAADNE1dqSV8G3a4v3VRahcsJE/qdyQ82zI4Jnsf9tim5s6iyQIGysO4YI78XdFkgiseF6bPPpZ55q8iPmnisKw12UgG5fVrgIaoI8gvhgbSi6zmDoA2vCwB8DMAlCtaaIAHabb/OqZmFxLX0nk33jEm+/C7emyyZbQJZ5HVsrhnEP1S4IG2PCrprYsOAEwueyNVDO+1RI1SowH0AnjrsgtPzmYAaDR88cIR34i5ed2VbqOLN8o4AAwe6Bbl+TIa9Ez21spS1Bg5LU9fxmGKtSYDNGr6OLtuRHzNNlO3XWbHIcJZQbax86i5tZCGWi6MCpSrc9ev+3Aw8xxqVgEChF9oX8N3X+ltiASajvqVhF6oSppit9FxVG83/+HcC+QTz1i3bKx3PB/S/CHO/fI82Cubfx0yvdw6H6z14cplJPGfQx4AvubJhDoNEt+OvBYgx5XrfxNEV/ogE8Dn6IlP0ykgenoW/7e5MIBu9nOdCB2it/hkqT1vscCGAEU4suEsVwTZGXZexKnnuC54wPMXljpDL6cZCy3CMwDRHuif3DGMgktUlQUB6DOw6IpXSmrOEeNHwKHVhYSbOpHSTsS04J3oWFxcCAMGGEMMmgUtanscGCGjw408QFBwuQp10LKyKVFPjnU5IsRoEjMmBlJdgmQc5JxDsTNZaC7+y9YbEyiv7vDQIQrgnYVE1MAB5c4+GyBkJ3XkRE+ey3q+2winCmA6R2bJAQnwlUqE5zqVIIw781qI3VjZHD7KriaKC2UvBQRKX65qlO6TH3TmGK7mJQB6zKOjQ0h2EAWAy3nLvGQf+ZO+Df94oHadpIBwuomVb5oPmMG0UxqB1qANPqQtoCpelh5wnQfwaIGTNIADChAeE6UFnlfB5C9twgIYeFIqJwkOTQYalN6g5KA1KSirxjmS1W2lYzZEplUUSRLuGY8tCXMYzqRYNYoMZDPtXEu1uCXPzhyAAQ3JWol0Fc9cjs8mLjAXIXly0Iam5jc33YlCe4rTnBK0glMZpbSSBtGQ3TGduoMhcS6KpYxC5ozktJ0TReACqp5kKTl5yDcXqtWhzMQn4dwqAMo61LOZc6qLlJhYACa6pRaoqRx56iMhutasGs6JMABNJyHQAAEEFiKBJawABkvYBjiEJ4ANbAMg8BABNKD/AiCoQAW+SYHKUhawD/krYnEDAMYKFrKFNWy6nChDnTXzZspbz4qY86LYtTNkImlRQQ4itYu8JUtkiSeKLqiQkg1mQs3Ba17v5cRNElIDFxBAB0TrEAG0IAQCmO5lqUvYyzLWuRcoigAgIIAVkKC00CXBCrxb2uU2t7HWDWx1HUKB64agBeM912nNmTbuzROi10HYAuISwlwWjyKBEdKFDBO4vQRst/QqzF0C55H5Lc+HIDUu+qjCgRoFkicgaG8IXAMA6nYgBB1I7EMa4FwBgMCsZqXudFOMm8CiOLER0Il2BbvhDgtAJzrhcHNL7JATj3i6Ca3VaWkpwERuRL+P/3NrXj4nLCZVNEng6ZDdOuUl0e1QfoAD1A4V2bsKNwyU2dzmBIWC2Q4fNgRrpu91I3uUBrBZAJZlCmnbTNozV6DDP44AY4cM2TW7mDhHHmRaoRiryhHQhy4Ci4aiRKhhIRNDGkKkeKRHkOaJaEoubJCX53IiMIf5uFUpQUAFqWfwdgAiODivdyHyXe/iYLAdMO+cH9IBEqDYsBLgCWFxrWqHoHoFzl01rB/L2cB+V9Yvc5N9Dx2dDvqwrUqGdJSLB6XPJQAzBuEUSBf8EAUIJlaoq5BAGBNqUf/oyOsGJk0J2QDJfvchGqjAXyFw71ffGwIVeLV3KwDv0V7gBP8GSv+fK3AC5o4X3vV29UPqre9827sCRUHJQw9HVHNqULX7pTYVI108M0qmUeHx00HGDUeyoAWE4/by3BbZw3Tf7qpL5A1KKE6Tmz/kBRGgQDe76ROe+JwCEaj5vKeS8/cUuiYeNRZIs3bRIGGp2rHVSLIOxayT3vZEIV9wQVBWaXJz+4vojvni+EpIoUDlqzAB+oe5WvCwrngpaVcsVdZuceTg/V6aLruok9vJtfuUNYFfcdvPuhPbEF4mejcO49HF976HGcMUlI0MaNOTkUil7ZmfTeU/e9C2V/7ynP9s3Tdyd6VHXvWpIzMFgwqT17s98FCJfeyZre7V5z51pTYzcLT/IhSkq8btwydyQoW/EZzYXmE+crzunQ8ndz+/ianXSkR/tCBrSp+cM9d+nJo/Gme3rdLda2UCaviXrLWOwt1n/0rO3v5mU18mRb1ZERukgAcqZozmqSv8/Q+Av/u/HPk+0Qi/AssZGtqo8xuJWVk/E/meA9EVxgAahdCIpzGA84it5ugWASSkyetAHCHA0DBA9sGvjVAmmSCwf2GAEimYIznAZeK/BMIkJwFBQWo9GyQQEawZojoyyeEoA0mWfvIU50kaUXmIjDCTtOAycGMMAshAr7G+HJwg3ptCf3oTEkQyUkLCY6Io4DkMBGqLA/AerXkdKVmd+XjCXNoT4rJC/yaKPjf0IyzEuGc7k6oBISp6IFZ6EDHEgC4EMANiwhPiDjVkkgWhDCmMQ5nDKkXcjx30iizMIHQaCQUwgBfRmJFQKZGZEm4LrrkogBdkH8xAQb6AwsLwiCcsrkYkGxhggVXUj0fsikiMoqY7CZKZHgQykqyhJCKRIlSUQKmiiBPJlVx6HlB5RdsJQGRsPPmjGc9Zxk7igBiARthpxocRHqqhRkLCQW0sQGvsRnDsihJwiXCsGXY7R3RMR3VEx3Jsx6+AQ3fUiljkCsdLxAKEuXjcPhXIR3n8RnZRK/mAF4xhkKgjDnzkx15CAVdEyKqYx62YRXt8iESDogtylYNkyP9O+oAA4CSMBBl/nDbxQ8BLWZseuqLIICKi6S1E8Z4xIotmQcQN7MjCkUaZrAmH7EdDC0kTzET4Ich02qOUeIC9aB2IAAzBcEkD25karEmrSQFtYsrF+8ib8cFKmxyeKckjS6dL8ov9+RxNs8THUUWoRJdxHEuzib+cPEDe6aGL+UKTdKtbWggtYqALyRqx+Mq7YMPLMEuaGYGa4svKkEqOC0loo7BTHMgYiQxlQkV+4kpBwTYpwctDDEbAlBkR2MfKJA7BZLJD0zg6orC31CcD4ifG0LaIWJRlYabDaJKySMXM/BiFfE2O2EzdMaeP4hlGQ0z1uZCX4iddoQyrS03/vOTEXTlG2bwXjeRI2bzJrGDO42Q/mjxO52zI56xJpyyzypxOqtDO6ny+slxO2uxOavRL6QxP1RFL/RiA7BNPfLlM8JzDtBRFlBDCyImJVQKeBFi/l1BP9rSa2HxN7vTI+NTClZAwfjkUkViR/pOY9exPdElOADXPJwrJGRrJgTyIFpIrBqyngZweormlJjkRsHTQmYnOsYG16DqswlLRyIKIBpivZHuIQFMvGqMx9Qo0ZAusFvgx0FrR0fJRV5FQtFmjjPqQi5nIE8rFkQDKutmUkAOMBiXRWrlOq/EJwOqA+XJRFOVRwFoBEIAAitNR5yoxCQiBE9ABASABCLgs/wgQLx04gRCw0uaC0XmDABAwLy4lrL86S9w7G6psH44CEZEongx9j9I8KkhKCb84QsiIUiltle+kGZ3Qsw64gBaACEoNLO5yiPQCr2ODrha4AOfiN50IATQVgAugMwDArITTAQ+b1OayVPqCgFrb1NlIuFHlU+ajQ8KkIqwUif5CmVcCw+zhtrhsTKkrEEd91FUhT5ppiga401CtuzsFUhBL0wv4VApYAUv10hLLANLK08KCVmm9gBUIJwi4APG6s8Dy0tJbNyEFSAMDzYQ5lFI5QRNioANYTGaajz1RVma1TMy0GsciAXXF1HV9rmu1U37DDRAwWDX9MVxLOFVFM/9UzTUTa1N1VTGfmCxYY1ESaFi0WrqMm8QLJaAz0sTyyJADeKfRnEuEGBWBWNaArRMUyDCrAYEeG68I0DPGylPAElmLTTEVg659k6wbgIgb+DeGewidJSxVBQCfbVETa6w5O7w6gcjbPFlBXYl9DRm5MCmGQFYGKk6ardk4gVDDaQqyGoka3Yhw2gie87mRELrDi1uzojG37aricygBmR+0zSsOSJXbwdoVcwqkkAmsXQrDNdzp8w8kDVxfcsqrUT5WET7LDUHJ1R30tMFIpRnFO5fM1dxHpT9DVTQBHAETqFLTwxee0ADPa5UAXUXTJQ7MWDL/84CBfRiecFxWCV3/OqnHzoVZ4yhEOxqOiXoT1EpA20XdJ9xLAEotLxmIr6uwm50ZuPNdOqmNURtQd5lPXQkAbbnIrijEB5irRZsa/eyOuPqRIU0L7gEitgpFXDFBssjLQKWqNVFOhwm6VR26mSm6rOVVtSxQICqAOSK78l0LTllQaTMwJe2e9vURQxJIQP0yQlPC861Kg6CyEzpbJhrc/RiI4a0Jg0O4xoI3FV5hFm5hF35hGI5hGW5hfwO4kaWJ5bVQkrjXDnkAo3mMFhHWsfWtTWGObERgixiT6dkX3NpEDrIUjfhKj2gR8TWP14KTUUJS+V0gM+Q036lgr1EBsfElFfCA0YgnfFqI/4kgYZgoDEyriV6LsVyzMzquYzu+YzzOYzumtcAS2SIj4BIk0o1AmAeoobq5m8HA3wMgi7CNLcFRsJCTwf2xAEHhiweaJzyRYk6ZiH/9LyV0X3klJiKUNg0WRIRxAAuI4IeAAQ8QARjg304yAXL8CjQ+E8yJCPlFiae55ZqArxmYlwkIZmEeZmIuZmM+ZmROZmUu5ubYLAEeYD+lpR9UpBWZnnPbIg9eTU07X1TCsifDCyfcF0ruPzLEP9UsIlOCEI9T3pL1kqXaYpWgX0kEmLscFb6AORfggABggRHATiZSXdGoZQO75YGQo11ZQK8jYpwTgBOYgHV8aIiOaIlujv/AAt5d9d5Ki1wliaff2SIw1rRpuTS4EpiP2JcDMOJFbg5YIqCUthS5oV68qTY3YbpdoTB4jkDonaHcKtsmRYkPUF0P4ABGFCTdDQ2BduM19q0M+cPB+BOomQpUdeiJnmqqnugqCICDe68/xmhAXV/sU1TnscBc1LRw67aOOyG/KETKUcEnzkMp5iB7kmnziUia2AAUEAERiIExpqDrpeV1S2q5QJhAzRCxGAia1YDAkuoAWGbGbmzHfuxgDoCr3iy8fVyS7UyTRcIEEAlWmpAtAom/6IuU8xItRIDkQUK5qIh9eQDG4EUl6wyWPUzqiJ4BQAtRiet1Ph+6tokU4AD/DzABGPBn21mTqm6OvhrNNCZoBluIGmJjwrYJgVOC4p5u6mY3NUC4bkK64AVkXNladYKcTUQenh6AlPa6G9q6mBZGbtmXkuCWSAoZruQWBiCAk/bQJ1sS5xsBFtjnWV69o1ZjXJaLtuBhwZ6XfJ2JOVPs6l7wqpbuAGAundBu76MTyEPbD4ABEwjq3S27/1Zu4okWiIgnPmFjmRCKxBZmBk9xiXboCXix0dWlOKlwyd2AGMBrFIDlMOvwpPYVDnRS+Y0npl4J+OqAE7g379I3JE9yJV9yJm9yJ3/yJm+AHggs7e3TzUWXfP7tfmbIFENVAZiBcPWu0EIseEMsVJsz/6ZdOMk6gcgqLMAaOMlS88qC2tBSYTsr88jiUdm9cnz56f1mgaF2x8syq56r7P/tOYj4Jp0Y9FVN9NLDvLhl9G4CikgvdMTtXq7YbT43jg2AARHwAL0uR9kovMOt8pv7udLjXtawDbqrO/81upXQCQmocrS87F5FCcAtjCoR5U3HihSIgVZ+ZXCUAdnoXbvr25UQiqZQ9hJv3ZX4AVk3Le7+3l5hoDlC4F4PjXwOgHEU7mWsbJyQcIpbjZzL7twwPagI90ZPCoTi1MQ19FWByAqtoStpIf85oEZz79uGKgACrvJ4wCrOdgD8jAAQ6mXEicpiLEydrIR30TR3USv4Uv/J+iZNbSwXrfjSwizHAgEr4NKHN7Ez9+OttnUYFGRKkYtoCq5KeQgnmZT4eLC0aAgHYMELqV6Bt2u8DvVXhACEE6/PilYZu/haiwCe+AHGYq7EGjqGTjgdq1HCEjgd6ybASrgG+IGoiIB2pVogI6wvfXS/jeb6vOA4Ekq3YO1TDsvm2XeWO5hSeUaBh4je/m1ht8IM6LUVaAHnEooas9QOIDbI6nsqX7GpF68LAOA5E3MudazDJ3TmMtgW3bEY83vo0rUG0IkXlymuXkslkwhBuSdKRqc25JQ9QcQuW6R5Qd9ed4E/728Q5LnGNy+t7gEsBfyh47nmIgHxmnSsBy//wjd8dcW1E8hbADiBXHN8xk/ToV/0NJ3j2h/y2e+BdU+JicZxWJx2DgapwmgkUQk37CD9abqytffDt6eJC89wDthw/6sxLzcsoAgsNJV8EKM189Jb+Kr4GZNaEGB64X96ygIIABEANBBwQQBCCgIjCFixooMAABIBCICoA6HEgRM3cuwIAEUJjyJHkiwJIIDJjgMGTCQQgACAAQ8kImDZkUEADAAcBMgJYMFLAAQMFJDo0mbMogAQGNjJYIHEAkpTUq1q9SrWrFq3cu1qdUMMESJibPBq9izatBwHUqjQYEaPCwMjMKxwosKMBgsJ5nUr8QXBCz36KoxQsIKABnon/yoWgLgBW7dwL+gFTFCyXrp87SLWrPHqBw8u1FpFeXVly6ADDPRU4MDjgwCvASiQLTFBa6ISHTBAMHGAUqYSF7AOoAAm6eTKlzNv3lUFBw8mRnxwbv06V4UbC0+UAIDC54kRtAMAzJYj+Y2WLaNvP5A9+I7jAXjPuHWEiOrYN5reb7UAA/4JOCCBBXr1wQgsBMDCaAY6eJ13EdQnXkoD1ceeBBbKtyFHEU5oWYQVelUCCgT296BHuqG4IostYrcBDCZ4wEEKLtqoFXneTdhRBjyOpONE6ZmUI30j9cjRkWilEEBZAp54I5RRSjmlVSmEJQIMTVK5ZXcS1QeekBJpQP+XBttJ1GOZRaq50Y5edlRffWUemd6YEaSJ3nxbxcDCgE9y+SeggaLoAgcBlECdoDemyd6dWmlwp2V3ttmlmH9N9GiBoangZKKdevqpcwiWEAAHDYJ6Kqom4cfpWcCdZQByEh0QgG+p2nprVzCK4EEMNeL666kmlLifnyahZpRqU3XkUqzHphgrsNFKW2V0JmQ5LbZUquCBltYVW5KzzCY1krgSOdsRrNmqu65HLijIAqLsyusgB3xi9y1J4aq2WgAGQLVRuTHZhABOvUmU7gIMFEUrAAUYMEBPtfbUk1Ir1fbUvBlDiaCMHGyqMcjWaXovVvrCNIACUD3QFMBBmcv/kku+IRDAAQDAeoDCEjEMYFEAclSAbSjD9MBMIRu9IlhikXU002nFSPJpE098slJA1Zya1AGwZEHRNvtmAFNT7WzTrFdPlCxNLDe9NoHQSQeDfmzLbZW11+E7ksnjAjArtAGjBrHUXzNggNljy0pzw7X1RHXaczvuX4ILmvo45RxtGzdzd4uUt6s/2ZZas1tbgG4BCRgwm+F700ywUmgvpXblsSsHY8e+Pg4kqrifxQIH3paMlLgy0YQUsqELFeBOD8CULso6+1YA2TQD+BrQjL8uO/bMWSkWCt0ePeGkP65JqVeT6m5S+Fxt4MHHmf8OekzFucaR3wNPPEDN6Tqg/wBLqZe9f09iYz3hZK+AyiGUdOIVskadhYESgYJIINgRB64IBSZwjuYMqMHYiYpUk1MXBX3UlRCKhIRVSdJyRDCC5mRwgy6knK54ZTt24W5CKESfm9JnlRpaJUk65Mrl3PfCIbrQSh7AkvdA9kMoLXF3MRAiEaOoQXctSIG/mlCZ6MSRNDFQOwpRiKQ8wkWPYPE7ZjzjpSq1EROaZQMBmKFaWkiVzkmxjtLi2Iw+eKsGQOACEIDARv7YEAgsRiJ8rAAhv1MmHPzRj4UkJCRBAABMgQCSfGRMH/+Ig0kq5JCJxOQKBPBH54BkOXLcCOeU1ZGpoasnsLMjLG20ARQoLf+JoKLAQRAyg40gJAS+nIEXZxCCDoRyIRQQwAwQYhDttEAALbgACSIyEQGQ4ALNbIFEcKnMZIJnIA3pQAiAmU1h+hIjzfmACpVzyt8Az3Uj4ZtHzhXLedrIbdbCXKcsg5ALnECaEullOXk5TMeIByEnyOVfnGnNg/Byoc3Up0H6KYDPIAac/qSIL0Ngzua4wAP4PMs6Xwa/lbDGXx6Bp0ps4hILUGxiCqiZS3ATgATQs6bWiVzWcqrTnfK0pz79aU9CIhCK8JOh04RIRSKCqaSKskx02edBI+LNDhAzmrwkwUMgMtSI5lIzGoAAQrS6VKRq1TokSk5IBTbSlAFgZSf/dRlHjhVTjjjAAKObK1D+ZdO1ATWtseMjQhmjzI1SZJ+SjI8yHTlNhFRSkhNprDIxmUupKgQEk+XlYAvZHDfasitpBZzUrGe1jqA0riotFvSE0h+w7VWDfnWcDL6Dg4Iss0h9BMFjNnIYUXpHIQZBSANwoBAZENItDXCsRECgGLdAILYUmO0+I6IQCYA1t4KtgGUB2dvmlDKO7yue3ko7EXhOjGVy7c8CZKo11U6Eta0t4Gsdl8UgrSmLDrxTbM1IHjBiZb7ZPGN+JzlB/rrpnKLx7mnaKdrPbQQo0GInstqLv4bBbLW1micdB+QSQMVXvvYhnw7Dg0KNNCo8HFKj/4g3YmI2ka85+PkoVz6r4JgUrSYeAdpsTBthieTsAPxj78Eu7MJUkoQ1s+EN4n4mtQfoNZ5K2fCfOsy2NOWXPUi6IQBQiELL5LdM3sHymYpEZUtNRMs8ArNZhwXS76r2ZPLLseoiliJXAnkprvwxlL1GRCKPhDVKAVqSNwK04dSmyXF9spT9k2i5KcTKtsrQdZbU2aws+r3N4Ry/TMqRhyHvYYGeyKAn8uOGuRImgO5XTHtCU1K3BqYzVXWBKs22+qw4UeFpIlr2hBZZW1o5nGOrWzcNIAQQQGGfjsqJcDwzUzPgNZ3DawCaXNe7ztRzhoaaFC2jEVxT6TwA+MF+Rv9mFl73mjSgZWXnRrsRsFlgJQWYmdlAfSJ4E20iBnu2hX9W4fYKmVixFBJdAi7wgRO84AY/OMITXnCPOJo5qxp3uaPEZ/F6bVarQ1x5SS1o2Qxg1ePCN79/ot59B9lE68KJKtWCyAYwd7AufznMYy7zmdO85nwUZQUowG20CAviEb8Rn4ECZz0/gKbw7kioRVpvHvsG5CV/WM1Sm2f3sipVsSkaUHyC8pFkXWrXJskxK8ly2ta87GY/O9oTY4U/enk/25p0Vcj981bNWHhLIV7JJ3J0JctqABhbdsOa3dbThrzHeM53n2519eH0RCdbF0nWv06VgkxgAj2pPOYzr/n/zXO+857/POg5HwAlTKAgaMROvbzSV6HO/TqcezO6hLz3jU+MyfJG9XBKOnWZ3Znkek68rRbvOa0H4AG1YWuDeyL5kvQIIZbvK/SjL33of7LhBm5f67M/JbkbSPhZd3y1caMAjkQ+Kz1i+fTTr/71T6AhYbrO07Qv/yhxv0CxySn4i4KBnsS76z1BnlUIwAk83/oVoAHy1ARY1c6pRd3MnwO2SACgwAFO4PqxXlsVH+MRX1GU30RwIFYc0wUQIAWOoPqxQQCAgAAsoFoE0QO2oIPUH4F4X+MBwNbNDABm4PKRRI/0QAMEQBWYIAkGIfQ9H2I4CO+4IBKaXPBh4PDl/19MMGEHKp/5AQBiPJ8ICiEW6pTlFUJCGMj6YF8SekqGUcWs9BtVlI5IuES83QgMDogMEh9OQGEURhuOdEA0/RFYpZ0e7mHaGRdhEYgFheGf8JlIBMBUJJ1WoKFHqOH22VGZJBUh8aEkTuLMERIfaVaBpJMgUgkheoQhyltXKOKyHJuNtCG7ZECtgcqjeMaDsOAmSlzdZdq1fSKyOY/AXMy/sFQAGIwDAI4B0JRLlJpq1Uwv9sQADN0L/lwqfhgznlhJLGN4LONQtQgLPNErwuJaqcwrncQhmgbDCE1bzQQGMEDU0dSxFB1HGN8wxoRr7I/HoYgpHs2cUMhaaIaZeP/EeHxRR3xRfHgEwNmjitFXlj2IG8HRNbLIuS2O3qjb2eSULXaOcIxjrPDEv4hihKkhRTYOi8SjvIAACm5UBDwGcOlWYhBUNiEGYyEXzrHcDWzEDbgFIvmTRypTzk2ESGoWbR2GNPpHdx2ki0wcXOlMNz5kcLCMTB1HnqGhAyRAHKKEGgZjxm3kPPFRNZHARlRANEXWYkEAbrkJCFTlJwGAHeZSTX4HSkJTB2BSVUpSfWBXHmIWQpBABbQIOq2QT7ZI0DGYUILiSTRdUcbVS/UHGibAcbAXRuolBNrRkRzXCjyTV4aSVv4TNflRkKyANa2Acp2Jy+Gkyy0mCDTmBaz/AHn0UVbCZUOwJYt0FIzdJYFwTo3hHTfy5Tf+Zem8RrvZDFQsgALQ1APYRGysI0S+44NwpLoMREVZ01Uy1QVwUS6tACBN0zNBxFwORAhchEGUZVvkkg6EwFAdZzMFEmQup5jkknTayFmxJoq8XmsgIy1qXF/qjXAQgOK81E+UVMfVZwA5JeIA0C6mnIEQZ6roVEjUR0F0wHdikjJxJmZCwJ0gRAtAxGJIQAicwEWQAAR4EQREkw6cQAgQaEU0kz991WcmBkkiRFiyCGehp4qmBICiiubkoTOZJmFllm6BqChNREYllcAlVUZNBIy2AGdGZmEN1o305Ioe6Sq5VhKG/4YeIemRtuipQKnsvJiTVulJKGkYnqeVPimWJqGkbSmXGpCUYo+ugakL9lWXLin7mCmbOs6YYs/DtamcMs2bYk/PFSJQWeCc7mmg1KnsvF0h8qmgAoufyk7qeeKgJqqtFCoHrWmSKiqk3sgHSCBQ+WT8cYSsjWFKaGqrCGekPqALiEAJwJ3O3GUD8gebBY9/boQuGkdRcKpZ3OentuAGsIAH2KVJMOqfehSmpqo7eYQCpAsAcI3emJunzmrroQCvrCai3uURomqCjZQscsTMXJvF7OK/EMwu+sZtSgQ66mZPjM5JMCWtdBxPIAcjIqulqYAImIBBloSuys4XQqtV/P+aNnIEYcZTYdZbzNjZAYzWufIGTSWMb2jN1dxnAthEwqrre32ArcIApXGFNEbjSOwkPeJjQFZsogTi2ZRMTi1YvMmTufwlsZacAvRMU4zjRCQATcHVfR7mgzFsLMHAjDArvF7FPDZjRgDkf+EjBehje/xsKv7jin2GdqDZjWjilUYreHWOeOWrSvxlQj5PgLjKqcGay67abjqMzNaUCpiACYDhVWjOTIKkSJKoYB1GkKCkAHjkNEEATLbkRLwky4HVY32kY5DHTZaoTgYKC8rYSFWNXlZr1DaOBYjrRvAE0NQMBowfpjbLqhGMinStHX1ADHiAmm2F5lAlNF1lVs7/qCh1ZZF8JTSF5VgiBHaeJQmkpSFlKDShJhVWEujG5VwKSjWWKtO2GY0NT0cEK3IUwExAZFMU224oj7eul1NU5MJA7m4wgOBRbh2NgAewAKlSxbd4Jmg+JpEuVjU953dYZgtg5mJkwGaWqDJh7zOJpo9C0+ye5vhsSUEubb3WHezRlXqdLHyyzMwY49Xs34URR2vARNb+xrFCrwalQAmIgNhqbk4JlXFWBHLapHIyJ0I4Jy9FJ0FRp3VeQOpqJ3c+cAdY00VBQHhScFLVrqCUUrw2R14Z8BBNagTaLFp4qIFe1M2NpGAtaIM6E4R6yYRW6IVmU4YKwIZ2qCF96EaJ/2goBakoYeKf1OUKM8fCurALheqoCsiPyuhF0Shj2Kj35ihE7ChE9KhE/CgTb7HLeUpHRTEVJ+EGlMCBtbFEjIoc17FESGAMyLDMuhFawCpV5FmglKEddwq7lsC7tjHgNu2qRuENugwgkwaATEwC5OAgq0ut3mol02tVdOKN1UasODIMrgZyIIACmGEmrwvNcoAeu3Ai6y5J9cvXlfJumoskp1q17QTgHGPDeBrDDOv/mSHhdgS4BoC4+lgARQX/9Isv9wvLfGPtnbKLfG3YQrMmz1HdAds2Cp3P6Ay6VlsLo4wDuGPg9UyAjGM5dgTU0hUDDKzBPMze6AbPRAXh7P+yLUahTlCzg3xAdEAsPnds1GQNyHIEsc7KPYMyv2Xk9aSW6hyAROKN/USMyt7GJNMhPSs0bTxZM/ebH/ezc9As9XK0P89v4B7Og7nXLJ9EN/MbVNKZQpcNABylANNZOqsOAlztTKXrhlm0I2f03U3MIoO0ciCwAgN1SG9y3QkunPnfLr6GQQcZTwxdS39a81ArXJVh45IfRXOtRRvAPQ+F88zKqm00UaOF5WLuWBe1NY/Uawp01xA0DSJayAUnhR3OAdTmsMImbbjXzCAAbyivzbDEAcAzUuSrAwQbrTiYUEzuWSdHR13xYsuvUY9U/dqbkCnATOxvAuzeTihOzkT/9QHIZ6uJhAXEoV3lXgDvjeIUjUXz52rY4lEq9mOfxRuLQJMSNRsHCsvG9nXAMAqsMj7fNpVApS7rdnMU8iGfNXATN1pVaotcMq4qN2RDd8hEsbLmsXSj9XVnTLyy6zSDCu4kyQuE90AOZHh/WQ69r0dkANJ2yXfTh3gfSY+EN3usdyNmslibUtMVMBs+iD57AD9/ihdlxdHqV88W+EikR4ArRM5iy+olKid7BE5Q8irFLH/kd5Q5SCr7NpQcSQXQbQVkUV28hWLoVkFQpkT8gGOwZO1mQGM0cZadXx4qBod7uACAWxkfxIgzhoh3BoFlt3U8OP0Mzk97IoWfjYVz/0mdpoAJDPWpjMdvEdYJIFXenqQAcIFBBBwAJFN0IdaTT1RGJBZGOPlk7VLAHYSVp64ydcAJ+LiAYFpJfZ0FJIAFqA1EskQxGscCgJbRFYzEHPmWjGlZZy6qgHmQTJaab0SUU5U/HVOXTwRZWZV6U8TqhtViPTl5VARVrflERHlivR+bL4e9ttU20iAGtDB8bs34FXbBdjPv1cw36ncpCoj0fnSq9AgIQsBd2McJQGZtfUcu2W19cPAJ9JEAKPjnti812bpB4HoFXICbiNI+edFkrcCaf4ZOfXpaJKTrMKRERHRpn/qw0ufZIEfJ6tmrXzh2CHVtf0qZKEYDCMalnP8tGlcAvf9XA8SFuwsYPxnXJk3EbLHcQQmYuwuGXmgHvaMkXB6GCSV3HQPlg+X2sJpXcAB2Lrs6ckzte8rqn++2BPa2xvhXSQSYGFGFCYn8gQvYzWI73Y205wxdUypknW9EYI+OyxzuKvk5lXCkFVdvlTK8HLsm725ERB/M6PTmT/zYAygF/ubM8RSvAON8fS/HG8fxoPp8G6uncQwdOk7EaL9zv6BGJDMhZtsZ/2Y8rLtIG1a3hve8ygti/Rn3p1p928+L3DmsfyOr3M89u5Bbhqtr3uu9usiaNC8wpP494DO4WfS3oOP94ZvbkM9Nos06z1d942sFkMdZ1jw+4m//hVATPuNXvq9aD0n0Mp1qheVGICKDfugLzJsXosT49G744tlHaVbsvBwbPuWGerDdvJI5m2/OPqiE1Gyve9fiftdqe0Dz/uMitEUSalXAsHXbsfHLrMN7Yq0UgOK8RFIC/6fIEdxX8vQzbF4i43uyDjfPCqhxv6dkkHNDc/irK9DfnesHHvUEhUnppvp3iuao/QsBhAQAAwEIJHgQYUKFCwseNMjQIcSICgNItHgRY0aNGzl29PgRZEiRCAcMIEggAAEAAwwECKDAwcIACAA4UODyQUoAC1oyUJBgZFChCCsuVGHChIqhS5mGfDjx6dOBUgk+pJrx6lSEUg0KvFq0/2lYsWPJljV7FmIBoGjZEgR78AMHDzDa1h3KterEql0XRt2aNyFVvgqzZn1rF3FixYsZS1TbeOxhADA8sPgAGbPThnoBS/yj92rorFoxSs58GnVq1avZvk1RQoRS1qwFbxy8mfRf3Ls79+3N0PRs4cOJFx9e9EMMDyiMCx/dEO9doYabV7c+fECBsQdmXswuvOIIDyU2XG9sFcAQveoDZ5r4x9vCIbclsPdKsJPCdOwR1vABXSKXBBxwwMvMOxDBoEo6SafvGGopppoYCOCAjhxc6MLVAoDNhQQzG4MKS+JAaIwneEnoiicsSUgLKq7YSosnXjyoBiaoGKO/Jp6QIv/HJ0JByIcmqJCkNIlK6NDDJJXEaMGBUFIpw4Ra0g6AAlyqkKMoSaKStQBQMHBJuzIYaBwBOhCAiIHGFKSBGQSQAwAZBiLjFQEEOCICgs5wU4AkDjqigTN5ACCDXAAAQoAVBBh0KiAgaKABH+QcqA47BfhvKm4EIIcRO14AIAINgJMIBg7CPBVVgpoE4MmVWArAgAWkHICBgQwYgEIADrgpgAcGKuBWl2gCYCYrXTKAWAGpLKmlWFkV0ACVGAsuVbIMisXSILYYE4AdKpihARpqGIgCG85swIbNbBAAAgj0OKiJBk644BqCanjDzgZ2mEqIICzVRVQAfGjAzg5ymGr/FoIFqCDNT9WkSKIURKiW4iRXbXUABWR9AFmEDCiAAQQIYMDKCm/V9eMqSVZ5oO60tDKmjDfumKAHFGiM2orDkoAHOytgd1hBfs4XiIEAZbeCBs4YaBtLBWigiIGAaAACSxlF4Od5IWB0kp8JrsAHgXJ42lJM3RAABLRpcIIgbhPKeSAPUtCZbutwJRBKKhfI9SADELCgpAIQoHBvWatEtgCTdM3VZS4PalBvvp2E+yzK6w5Kgx3szGEFCMSNAJATBEij6m/skCCLp3OooAImKDCChqrvgKCCPQBwgoYLGsgB0n0hoQHSKRqoYF8fnoYgh7T5AECIpCswI9ApAEjC/8wwrHk6Ed6IsogDui7/XriLIR+IO2kJ8ps7Cgc/ACUsUapSce4qbJygAngdf3ECHEhgQpdwBj8kBHJJCQ7Cg58FoQZpsEIDgECG4V2iW7QjQhEIhoVuQaoIqbCTFwBwCRBUoAhSqAAIOGgDCIAAHXcYXg6QEITh8QANdkoEEsLwtGC442dEqIEjVtCAIWhBACRAxDqeBrbcbE8iIyAgAJmIGvHlbSB7i9D5aPIAoKyvcL9CXPwYRxMHIWBlxILiTgKwPwWo5H3TaqJHchYBL8xrFQAgBKQEsIQTwgEAa4BUEGiwMD8ZsAF8pFoZpvczG/irAmswBBxucIEl5EsIGv8gws/AYae1AYAItMtD0mgADABIYWE2aOQbaiADOmxOe26xyAcCAKY1vjIxT1yJrwCAAMX1bVgDWR8ATnaAlCWOfF0EwAMUB7KYWAlKtLTlMBWXk//BUiM54wHB8sA2DUxBABdogQCYMBVskiCbbiDI2fJVCUJ1K5uQyoFX1gVOAfBhUjYY3glWULQM1OAQPrvBIAZSA+BZ6ghyGlgHLoApmVzEBEiC5kLZIstXvWSKVDzILneFk19xcX404QmsbIKTBrUEojsBqTPVyNCL5MxbJCAFQfpQsAYc4ZzhWAEJdMeDDIwJD07rwznxcIETuEkIBDmCmQRAjRpw6wxDy4b/Ec7ZBXdeciCgBGe6uFULRaEhlcS6CApMZVKvflVDYIVIzpggjG6OKQMUQMNM93WQHODAFTMiyA7ahQwJuG0HVJtEXoT0hFIgJF5U4FFDavBIK8CJsDZ4AhWOEDAAbAEMT7DgqCwiMbFeFrOKsZxJgzMmSUxBEwNxGBJ2kIU13AcANQCELBqBkCGowg3HIE0xtPCIcXVlCEzAQhxQmwkbXIG3m8HDMOgwEMcuoAnmEIioBKICUIgjq5uVW2apW92ybJahm60NRB5CAQBQoDC6WYhjCeJd24wVI92z7nrZKxTsLtRyqGWId58j3iMypL4Wya9WL6LE9v4XwBx5LzSD/3MbzQCAvG77jVbyG53ABAgjrHRlgCmsEC1ZBJgH4U4uw2IBZwllcIY7aXupJd8Hc4Y0o+FWdPiiYAkEzMSEOfHbMpLQClPYoY5TCLBcwgALwK8u5WOKhzMyYFhSK2Bjcqx5QSNjjDzkMxYhb3klEuPHZYSrNw5wjiFigQBQyX5AbksCbjkUB4SsSOw1ckQeouCLjCYrbibIlAOYEctq+b8OfdWHCcIdHR/ubsPqzgHupoADGOslWAIjrHJV0V4phAEYIIgDcDWABKwFIRleCaYT8gBaWmTNa4Qbk5dCao6YminvnS6e2etQjQ2TZrosY0JAph2QtYwmCoCJAx5gPv8HGODHrdqbyUziSx1LUVXF/olChMwdEdM61uhVM3clImeNxPlhTvaItWmcEfWyer13G9AYh30QK+0Yo8RCwN4kjW4AWODThAuA4YCFkDTWZN6/4vRBrPjuMifk3hCetm+owm2G3PTBftE2gBCCcI0Y/L3+Bbd1uZy/ic460+meSfsOsoAECMgkF6IQx59lb7Dc+zEL4NVa2odmSrsEJgxK83pDfZA8IeTm370vQ3IOqieTiyA9H4jQpR3hmk/8exVHdp+/TGuNrzsA7bbVACoEzAT8uGUHyOLhELJ07tTvij/eugEU0DFCO+DXXKr3iAfOkEdZ6iBOs1PcLdUArSj/7HgEKeIHK2BeCrDugwQjyNvztRm8C4DuThN4jRWK9Ms6VJn/fnfTa3mzDMtP3byMea9XtiuTgLHqueplyhAS6fPJSuWcdkC+q0T5gyiAS56euXVzpoELEBXxem9BCATAe7/33lJ+V9iZLhAwdiUKnHEngaKqZtzbn+lpv7eT78kF/BBsc/EYQUEMHJ9Zh4I05rTuH7DFjPlB88rQg4OVAhT38QDgqkKO/vRByEyQjd6K0wPA+uKwVL+bDeTMOKzoaA+/ACBtei8EzgkAeq8DQqAD7I4gAsVOQMDnIgABJ7AhCqbwIiBPhm/uBOIAQ4D38iRPDvABDyJQHJD3sq3b/zJCBSam+2JwLBAg2hhCyBjCJjgN8wgiAcLv3WqQsmhuIcbk76YvAfUOAVdQ73jvaXKuAUTQZ7wrA+Qu9waCColwaEQQAkFFYZTQCkWQCYlCgDjCA8pDBs8wKATk1TDCAhjg2Q5iZARwB3eF00KsyEhMIqjmAtrlINolUR4FBWkHEClAVHCgXfZwCx9FESlQA0QFBBSRaiIQAvYQAnAAwbyLaioAECWR+SCAKVjAe9BQFDPD/Vxi32QNWjri6ACoxOZM51zxIAJmyvxO5xzrKmRR20TFu2gxFo0LIehMJEaABUaRGL9nFcHn6PbrNJSRIzbgGIsRGsEDD6tsM9rs2v8YTCRQixkVMKs8wsaiERxP5RkvJziAMSEMLiPMcbxEAh1DIga4LxzjMUnGsW4oRx0/AhihYCH0MSHuETFeUB4DEkHokW7ia8EKcLuyMeGwYinKUCAf8jQESCIJUmfey8qu4yI/AhQhkiM7kiAm5M82ImfspF0gQFGoECVTUiVXkiVbMiUPsQU6gBuDQhg90iaJMSdoaW+iDgBAEiIW4G6ATepUScbyBQca4PZcUimXkildkgR+5vaITiSc8Sar8gxzMopcQtJ8ciFQwg1r4upaUCHsZAImIADMciLTUi3Xki3bciLNcgLYpRs/4hut0i7BDSvJiCcnxGZe4g297P//gjAhKIAs3dIwDxMxD9NOpFIk3vEuHxPP8nIntzIAgOLjAvNXYM4CQpK/FkIAegAtE1M0R1M07WQbXRAGIVM1ASwnBIgytQMDruQgXk5AvhKJFmJeAkAJSJM3e3Mt5UUsHHI1hzNVUsA3l2ggJFMre7LpdvINdwLeXELycsan1MA3rxM7e0E35+UHwmIjiRM8leQDRCAUR0I597LpBqdWGAIwxTIhFqYszxI751M04bL5wqImw1M/EYQFhnEozvM1V+LR+M0CsOQm/ixn2qQsrZM+G9Qwy3ICfiZPHGYoNsAD9hNDrQMFTGDCRAJAmbN/5k+XPAzmBLBl5stO3El0/5qSRVu0KYcHBHQHVBgzJJIiQ290OFRg1YyDOufFnVwUSINUJcGlairA55rCMXFUSVPjAzxgBKyDclDtQLzLH0XiKJYUSzOjBLqqOjprTGjUPMzrNEXSDLPUTBFjQzuUOLCrSonjPsY0I1jgSc+UTtnCBXa0Sy9CSs0jA+B0I2DAP+tUUMfCQhsvT4cwAyj0vyx0UBs1LEwAHs2DIr0qNhzVUoMiBkwgQSbVpJL0Uj+1I+60TCX1DF1AU0EVVe3MAwz1OjiVs0Y1VWM1IT7ABJjDQ1yVoeRUVnc1ITgAOTcVDQGVV4cVAMRDTVsVDRmVWGU1BTxANuZRFCt1WVGVVv9tVUngpmrspAUSD+6QsPAicJtIkiDAkKg4kAOJCgwHz1JaYAsB4PC4de7OwlOn9VL7Uxx9w13NBPskse5QMFEe0bG09VymIgROQAeCCAL8DgLASQdOIAQMgmA6IFzn7IQUpV3xbhPNwlTp9VNhQASO9UCoJU9+hqC2lSBI1k6Kz/nspHPirgUu4EyMNE9C4GCzqe/IpQKSUgcScGTNRJuqEABMMmVlMSljtjVglWPp1Djn5l4VglsaAARW4GW1ImoVDwlpyhPJZQW0aQVAAAKn0GkuVu6eNmpfdgWYbBLdiVu7di6HQleTVlDHszwzwxnd8leJkiGohqZI4CAq4Ef/gZYkP4hq9zZjO4CmohBnU5YEZHIg9PYCSIACDWKEspVbn5IthBVu69ReVYMDuFQVJQIEDrAKI8BrvrVxycZIE3cCKdAKaWd4buAgbsB57tMARfdmB6J0xRZ1wXQplDVzzTRNVcMZkTaaNoJbmIzozBUh9jQCKGAXB/O7KIAxTU15cY7KZnIsRIBpf3dJdXR7UaNz6+wjwLTnaJR3g47nbA4izhdJrZV7b7RJ5zQ1hld8RXFj3xdHt5Q1wrd+0VDC8DdDg1d4A4B4RbIYS0B+ARg87/R7wddzPwJXv6pUFDg8C5U16FckItirmpWCwRNSZ4N/MxgatbeDVzNTZwOD/0W4GDnAfUvYKkUVhB8YJDTYq+7Xha2yWVn1NFJYhYnxf2+YwtyyI6pVOEJ4JGjYqxAYiM9wzXxVOHi4h4lxgpc4Bo3MWItYhvt3FDmYirtvwJr1WVcDiqOYGEm4iyHiwjLi68hRI4gYi1MNHFn4jF2FQcZIIdSvO5iNcnTiVjVic1GYgOE4Gm2YiiuuK/lYj0HNfAYyIzwWZDPDiN0LHH8YgtvybrNUz5rlOVuFWB5gQmJujcFIfwoNKAXkiiYEzYiFf/I4rC5iaYdjjI84HJV4hofV1WYG4Pj4/Q4g7RYHAGJTJSzgZniNJvgYJWhil3b5OC5CbokjkiUZHKcYgv9tWYDITXImR1r4+NLyh4+Fuf/EaCDgTaIQeTYs548BuYDJmBjvbJp5teJusI5bRlq2mTsY4JYITTrnR1rETVjAeZklQoDfOCyQGKzMmI2EIo1BIgGQJeAGIqEp7pYwJnIi6lmyeZ6BgjswQAFE1Jd+rJv3zy0WuUskwnuJI5bTMB6/7aA3wpAXwstgjjMPOSEeurogT5ckj5O1GaMroqOHiUpgryepZGQAsNf8WRoZIn6L45mHgqC/ygUuuXhZOqLxZyHKTlrEOSMaeiViGqLj+aF8EBW7Q6d9eSdIBmQsqpZMMa3z2ajLGSL016QDWSya2qsoWcCyZKqhZM/e0A7/SUJAaMl+cOVjGLpX1NpVNFmXUFnQlMWhMyYAbLOLqSWgBXqu5bEu71qqvfrVOAYhevAnebLWtOhZtGNvvGizCRuZrxlmVuKMhklEgTg4GLg4ThqawzHLVloj+NklrPmbVwVDbO2W6u3e+s1Bhg2reUkA8YcG59g0LFips3gp6HqDUxOzczuvtzqYFtmzE8KWGFvThBss6s9Byke3acJ+BGSMlvuMTeODZ1uuIyMg8TSqrdurJ/ri3pA71uI7vpuwa+bHiruMLACkaymMlBsIX4mmP0LTrjUhTtg4llqQU3pu7zCzsXmWbjohrPpXHmBv0OiXgpuwDSdaLryWTGKo/2ui14yp9dL7wHWmpd9G7bBrwaH1IGDYvdOZqQNS4qo7I74P5igaLNVQO9yv7IC7fggbpIblqyMEj6muowqbxZvoxYkixjNixvuYIHK4OSA8wsPRril8VzMZVp7T9c4tWVyCShYtAH4MWAKtZRh7lm4CKFrT0J7F/U6xLcDCjW+8cgTyssFcVm8Z1mC8fg4DZlZP0pYptG/N3GYtY+bZACpkQVACKLYOMcDCibccuptCur/qtg3YnasZu8nom898QN5Gf1yv/K4ZnC8kjIbt3vxGswbiio2Dtrs8HNl5vgP9usebnImlyqvkflTirFfm8nLlvHd71DNPnmPdRFsDAP/AuDq4nNMfUr7ZbiQS/CaVDuPcosrBiErIGWaO/QDAXZ6X/dVHDixkPTFaqVar49ZxPRxVGtCZpNdjmjsCEyVaXCG0WstsusQJPTNV5phSggAGQFYwgAEcgNxVHJmWfaEl3cTX/dnRIgDO+bnz/CF3vN69495tUNmHCVY0wt9vzMdDisoLvSZ4JScIAJ9hhdgx6slbftlFPtFKzlYqvnI+Ft7fu88F8stBDa+9eq8RgjsGwFeOvmMIAKSWxbG/ckBo4qUNYOmb3qEVYEI+hlekReVcAuuQ/iYMYOFF+3cDoIGdedMr+yH/XOgrvKJZG5c1bCYoJHEWenG0A2NaW/b/UC7Suc7P3l5mVgLNhFlCKh3NHt1WqIT0MrfTRyLeq/0hP332mETUAfyb5UcB2pAA7J7Rhwkovqi/BwKoWQVx1tPzRz3DYvOXTX+bL6TeFB7I6bXxRYLa1V4gdR3be/zjLY7pyn3kOZ9mgAn0cd6fmZ7rLgr1Fed9EE2tL2T1bAnPZb/ncdz2BVI4J9/j6zsrIwrz0IzzTZ+40zz0eandjL/zwx/5S06jZ9pxepD16EbbWTr6gVXTL50j6b3t6dvCkR7DAQKAQAAHAhwYCCCBAYIBCgAgEIAAgAEOASBYuCCiwAQKADh4sLCgQ4gSKQosMEAgRI8MFpx0aHIgxJQI/2vavIkzp86dPG0OoPlQY0ycDQU6UABU54AEPScGeBrAQtOpVKcGqIo1684NATZo/TrwKtixZMuaJTuCBVWxVH/KFGrgqQIHNQseHKhQZdyiEyte3PgUwdGnAxY+3FsxJkqVYhfsVVCyolEGCM5aJuuWcWSdfDPzXNo0c4EAGC6bZms6NQAOHFT3RO06tuzZA7mupS07AVPXBRjg/j3QM8mJhQMYcFmzKEeZiAUOeKAgQALQFhkEoHwzc8HKixkC5wn7O1auXsULDG8+vXqcJlxYXQ8WImG6rg1Ihm9auFAFLkHabGjBXAKJFFRJkDnHFESVIWCQTzT1Rld3BeGHEP96FOLEGlhcQcVhhx52eGGI6sUQw3sinohifh5uBkBGd4UVl2S9DfQAU0OBZsEDAxlQWU0DcPiASxJamB6RKJIHVoZfGZlik2WpIIKJTk5JZWhADRdTQRJVqMBopQFQgGFgpnSjjR0iMFpgxAW30JAiMimiklohuWSVdprlQXngnTXUiRgEUJl8hOml5lE63vmVfixmRF9YDlnQEpi+CVRjX8ExZYFUSgHF4AFuhgjnhXRqJadWoSKK6k0swNDUqQgpailOw5lnH5vIseQQg3QdgF2qVcH6nEAIJHVeYgYcQCCWkoFGwKQfbfkqTUe1yYADH7lKG7brlYrVB12Npa3/r6im1SpWwN5X06zfIVAtQgkwsCWjHjUIppji9gTsY406apQCcxHQXKwT7cYgYS8Gx+EAd/0oXbixOSzeqFmh0Bq4916sk22vmXulUMUdl65GCFkgl0sQPfDUbgdEF8ChBSBlHAAkB8CfTQ9oehLNAZgs1ssDZXQrxkLbCfF33Fb1QZ5kFT10iu1t/GvHBvZnb4EIhelSXhA5lFFlBqR0QK29VYR1QlUDwMCXkh6kdUTXQYt2j03P3STTuEmMFcVl2U33hSRC3daKsbqIkLoAdDmgQStRmgDQJ7UJFOIMHQyAyGhXBPTiDELbZ9+e48f3bEdTlXQKe3+OMZSAT3Vu/+JwG+7hAYsnNABEd63UXeUdUm45oK7PTp3AqA9vXuix4V0VCiWYZTzx4im9U7ittxjAvoYroDZjAylggeP1jrl99jalPRADmO8M/G5xO88+cM2rNvpUSavAfPuprrpn1G+VdOiwIcNdgEMtoCMQccnmAPA1gogNKAEUyABthjOFHKQwQeFZvHZmvww+bErIo4ryzvI+DcaGXNHj2P4moq+QccghCYBKgoxznR6t7CkuS0oLU2YTdjUKZTQ7CEQC9j0RCtEqH/LQlOLXlPmBcIhU0hhnRDQ7y9RKVuHhldyYiMXPdXAqH1xiFpv0tCeGKIpn+dMVCwcbQ31xjX1DYv9PlOhFNorob2KUox3vOLctNqWLccQjfFRgghL6cZCERJQbeyIC+lkmhIXECvSI0shISjJEeuzJCJZ3GUZOsicsGEEdMYMu19BLNZ3bpCmBc0ieJPI0pwQOCSGpP80I73/BIdZaKEcW4IWylbxUTSV5csnUaLKXNtmABz5ppROW8oTOsaVVcDkWXRJzmvCr2FdE4ElWUjM2q4RlW6RGnLiADI2cS4mgDLCllllHQNWB4UHY9RSpkO9PQurIDFt2EpjtJTA/iU6ktgnQOX3rKyOIkjADqho63kR64BxAzfxDzlrWBDrnUZgDajUcFzmANBZJyc1kVpSPJjBsDhmb9pz/c6AHHAqhLO1JKneCTdUMM6AuCKQ3WSe4mBDuLR0i1uJEphuZrdQgG72PzxhA0bR5L0zgO2ms/tLSqObklzspqCilukg9JceEssyS5azWTI+8Cyrn2VJQh9Kg3lyHaxFhgJaqZzvt5U6aFjkbVqX6Up3EVKZ3NUsnb5rMrp7PepZzC0ck8lOzMiUBkhklmKqHNgXoyF8dWSrk3hIcv9i1rwilqk6selXOjgUGalkoV60WrI7SMqwPoAnKyroRpiDgUCST3QBcgoF2oaw0JNPUSBf4M5HFBKqijWpec7JXvhb3K8YELL4amsKIhtUxNBQLUHdzQ5Qhi2HozBldMvKl/3vW0F381OxyW+rZnIA2tOfNSje32t74fvG47Mkme+U7FYVWCL/8FWF6caI62cwUoTU1bX8PzD763qQE9r0vgjmj1fM8eMKe++9NAixgCu/kr/AtyzJ1YgD1kSXE34urhperYJuUgFWzGTBCSfuf0yoLJwXrELRyRxammvjEnLWwTVTggQ9ki8c4aW6HWdfQXaIRlzgei44dS2S8WlMrJUABblyM0PdKOJao/VjQ3vKipQjKIMNNiQMYxh8LAKVSoHnyQQYYzyh3dqBaAbKQhyznmui3cjLeD9VusuM2A6XMMuvIRxBAuI2WhCludgADmLKAXuV5mimuSZV/g2Wa2v80LObK6flwGWhGD9ovKQnQwRDH1IGV2CC5xYuIC/nhpcHNbOc5I6A3WzlbOxUvuK6JGS0TaSU3xcc1sTOmJ52cO2/5m8qsiJZsEuqmPhVsDFOYpGLV5oXYLk0uvOP0coIAlrXM1mOuyFeTo+t04dp3gGbaFC3zJ2g2pdIIufSxkT0QDi8byc12IGRDFmZRZ1ZYSQmbVIpKr2wH5QAY6Aghv32T0WCuUrRkUGXOXaF0F27d6SYjVXSYmuBVhdgIMfa98Q0AGEyZocrsnzOjDSFKpWSAHq2I5FA2aEZrm6j/LICwhwgsL9eFLzqZVbDUSbMIGcZ3DMOnQGZmAMPAOSr/tQ6ncXh2w908+SndnSjOQGofuzp6SzuuyYyyQu+BcMDK7kO5QFJwTE5zGUvRBfilPMIyZInTLWp1OgB+jaBVv/kxs/4isB5aNV3xZFaSrZxFxbb0K4K3XgdhqqMhjR2mIz4okMZgqmnkcISQ73EHgahNprORldpkp1QheW2C/J1MZ9l0+3a7imw8OMeOJnE4rDhHrxtEdg9ccgD7+6QSwhSmf3p2PAoiZpMDLeJvVqMYr1DheZJ2gaxdPLIP6PZrb3vLTO/ZA1H8jpLP9aA8xXywRX7wF9R0h4is+NzGofJ/x5bmW36sT/kPtOa/EGcmF/QxABaQavAkfJVzfRlD/2dZYUzKdnIoV2DgF35mMT3yMhAEcn7Qdm7Al2qAUhC7YRJdV3wN9x+VERN/4gDMxx0LcVhBMT5qQ4IhMQDWMkXs0nwywx3Hx3rzNmVo94NXFn7ecmfdl2fA4nI2QTKY82gcOGseGHkZgVi1wlgeQUGOhhw+l2sToSNHYU7514IA0FqUEh4ftREOcWZVIzlo0y4I0WoncXznUUQdEmEj14ARiHIMRoEViBnQNYARJ24JAGodqFjvlxByUSuD0TJSR3hbWBwBUIMwKBD6hxF78Vo1AXJ4R0P24jOuVhcGoDYihxvZBxZGCFAqt4dZEWtCI4put4pZ8W44wRH7ElQ/I/9p8fYdrrc0FQh3qZgTEKdCcpFuu1cW1vFlWtGKKPeKWAF4NrEyr+Z+j3MrwSYepFiKfCgCpsNygpUTw3Etu0SM0cQAsZgo0MiHtFFjMXMT+5SAwKGLu1iB27eNXSZOX6YukLIvOVMXLCNALBOJSpgAFiAm/XQdyAFPcXEQAgiJdEEd8IQdClkz58hE1niNFVhg84glmydd1CM+j1UTv+UQ3NMiCgBNSoVBE5FSOpJRDeJQ1qIANvJCC2IQAeIRD6BxEkk87wiPQxgA3tJpuKdTjqUu22ET4Ug9WbgQSKETb2gAmjJcC5EjYXEAG2WQC4EjK8UjpoaTWBQDQRh758j/YBgpFM72VeoCXoLCaKhhYitBACyTlmpSiwLpHOaFVrLTIVZpJhyCAAdQbfK2laiTNHX4lXyocmK5KP8mS3CYjx4ZXEiJRh1pHRzCIn8RkFK5UfmII1+HEAb3lxmkN/BhigEFd4bJhQS3Wi2ka0aJQGBTKwpQGbwya284iVLxlNVReSzpFzD5EM7yAATwADb3c505N4EJOhIpAqT5iOzEU8KIE/UXEeIFGE8RShT3dL5Rm4cIiQ2iiOzXkFChMH2nesI5PChQWqApkRwQmk1CXOJJSHBknufoAun5JiXDno3ER+/Jhz5Zn/uZGu6Jn3won/xpe/f5nxXYPMt4IVAm/6B+5J8FGn7IKWxj5ppnYTjg4ZcLykYE6qC2B6HdqBHfaBYVGj0XiqFZ1KAb6nbIKXQbiY8jGWdWOB9gok+rRSNycRcHqZ3cRTDWIWklaj/B9CY4iZwayUwceXktgh0teRSMxn5O6C7HsiYrOUGuFZMWoaA+OjxaRiEBuk3S42n+djBDCSiyqRtUKSyX1W5w06QuEpXnMZUnWQCYgpU3iaVzA6RBKpEdyhCvYzng5ZwJMGYxkztNZ5dwI3wRUZezE6dOoZd1yj5auqVC2meHSVg3Vi0miBCXaXbOBFYCsaYGUYVuWhD0saiZ4qgZtF54eo7ImYTShZoskYUwkZvSRv+jZjOlFkFbDdKUI5kgvLmApzo0yaWqADqpKPSHaAQVE+pAjbidJcWpgeoQPESS0aldLRIXDPCSwuKdJAqs4pKqw2qgcnQUdNqtcyOs4PqgX8RtmlmuqPOt6Mqh7Qqs5wqvKSqvjvqu9YpyBxqcxfOr92o/9Kqv+KanOdF30nGMBMFDkPiv4NGwkkirAHsxLmBQTsKl1FSw2dF14WZrvDKtBxCqpvKwisqpEosqejglFztNKlqPmHiSOqEQiwkw0jmXpgmRLoF07OSQFwcV6ciXUBGeJuskGGaxkjp3fiaGVbMcPLGrQzcSY2maNHlojjeVGOU7nUKyq8dRQkslKJv/skYbOED5adGirWqSHKF0dmJoI6RWaAcDfG2KQAiQtT7Rr1y7HkBGNGDLb9y4p+4SegzBszHTtFcjJotBaD8LiQcBfE0XGHPbUVBRt3abHvZGJSpLTHqKgdoKLURZEzFrdsfHZmybgbv6tpo5tyFYs5KLIiZXuXobWKjVqgihADlocc6IrQnJWMmiEWNIc2IInAoYW7tpFL0phYpJPVMYuaoLHJTbunlarMm5mDITmYNbEwvQdL15GDSrQMbBd5F5KMBnpQaDnYKRdzc0u8mrvLTBus27qum7lczLvsTqvue4vvEbrvPLh/Brv+mKv+H3gKhiub0UwP07Sd+HKAPc/0r8+h2L2ikthaCfYY43wSsR7Bqeey//C8Cu+1z9lhMOcEPSEb170WsDsajUBIxn2y+cmow3gXpnChXsahnZei8GfMAa/BlJphP+4hKO8bdk2xMlPE0nXCGJUbIrPHRkxxedqBplhyg6WTw2vBNB17II0cD+1pFrwnm9p5AkFlcrNElSfHX/wUKhN7OdoXMMY2tKnLYVgmZqBaXthB3nlE5j1SNNmioUyX1QvCnKRKQb0cPUK1Gcd5RYXCllNxrRi0eH92dnGyD0obuLJiklFYeUgjN/EiTJUYOOVjMiqSBWejAURbUIQZ1NfId3gsCn5KViC6Y+fHcO4lQ8YqZg8v9CvPOwa8S4T3GYvBMjJAy6ujkklNMnYcJ15rYlMaFmQrUjV5RYm+oreJzHznu0LEJ+fvyRUgEVhpEZLKiosyyjUFHLhofDfcslXvI4JEwmAjc5PrJLB4AyEiFcZEMmZ+LBkWlds9Zkc4jP+azP+/whgpm30MxsfJu5npyBW+sjNMGCE3ISs8wuxCxJF4iYxSK9QtLLqvbLXocTRPnOJ1FqmvmCyyzKFHxXp2xKrGqaNaHD1qrCCA2GCLTD2bpt7TIa35xFSHjSQ+wcx/LIFk0TdmF2oacbd/EuilvM8Cy8NembrlXPNWHH50XSm4ScdTcQHtxt65h+LGit3DvLitj/zg/th0knxv3yLwEjaIlDOeQ3LMmKHBvdVDWmMNTVMksNZvL11JMUmo6Gvqfawt8hw/FV15KUngUzwuU6wd9hwX6txwSs2PnTvovt2LcB0KAkLgpd0OT62IP015GUsUNHxuqYHXndE+HGnN5x2QGV2Y202ZuJy2SIaw88FX+iKS1UGpRd2hib2DgBxuNU0MFSEBSkOzTLbVC5figouju7jiLmUKTNLu5s2bVtRxaSAQjxAhEQAQMhAQMR3RRQE9kNANUNABKg3QCg3S9QExoAABkQ3QghAwCw3tjN3elNFdcN3+IypItc2QaBEnlxNZCVgm4ly9MWFDJ51gZtpQ4w/yF/kk7N7dxsZCTmTd7tQANdgN0CQQY0EA0Icd2KEAREIBDKIBARoAjP8AXnfd3k7QmB8Ak2MQa2AAfhfd4AYAqBkATwfd10gApfVgOPkAVDUN3XjTGpLJm5dzB2wT3wot/WFyu5BTeEBrc5WKQL91b/p+AL/kWh4gQ0IAAV4AftDQBIQAMNUAFi8N0CwQwCYOZi/uI8IAAn0AA+gN1lAAEQUAFtgBBfUAECEAZG4OJw0AAQAAY1UOdmvgQ1AQQVAAI2MOZCo6fTPDkM4oKG8TLeLDDmO5nxrJdoWRDZoysFwQBJ0Y5UTkhEIgE+TgQCQAInkAUAgAsCkQMzYOY70P/jAGAGHdABJ+AMPg4AOyAAK3ABOYAQWHABHQABvj4Q6kACKwABEj4QWWDmAgAEA7EMNnABLXABUvDidoDlHdAARdA0mBvRPo0dedHQsFVKyc3kMIwQJBYc9kQajVd1oK7ZOIHrSBAEJyAA2n4EAuEDzZ7l+S4BPNAALUDrJ8AD7J0EDXABAgACEEAM580DFQABa34BUSAQRXADCb/wQiAQQCAAF3ABIBAEu7DxF68DIRAENRDdRJAM9t4AiD40Jq1aqn0weRFzMy2GD5IAdHHMvKuUzTK8hQfbgDHbV8GZWwjvqK0T140GJ3ABS9ACAmAD150Dd44JIAD11b0DKzD/A5wgABCwAwKBBWuuB4YOCADwAtLQAA0wBxdwAlMQARRgA3e+9hAAC10eBGYe9wIg4VtAA9ggAHlg5hzeBpHA9HMQ8dx+3VyeKlF9rAU98wHIjxpBXejEMh+7dzTh1tAk2jQjQ43Bfp9+9HfEJEJg5hUQBXNwAwJQBFFQAScQBj6wBGa+CYJg5mBgBFnQ52JABg0gAJiABItwAQ1QBqKg7TZgBMB/AkLACidQATsQBWa+Am0wCEzfDGvA+zRAC0CQ9jug5h0QCU7AB2Y+BUnA/C6/3vNdw6Ff2x+CSdGdAyvQAWkAAA/fAEvgBQLQAIgQAUWA9wDBrgIJXwCKVICw/8OGgAtfAEgBAUJLkw4CzgC4JUBAOUYCGvAAQEdACzNvLpyYBiCHgAp1aDRoIIRCjl8CcjTQGCWDFwgNiAAAGlToUKJFjR5FmnRoAKVNnT6FGlXqVKpVrV7FmlXr0wBdvX79ulXsWLJHIfWsIAToDoYaaRgBEEGPgA4VbVAAQMEGiLoCAgGtwQTnigZYgG4B0wBCz0pA+yDsQDgH0CgNWvSdDIBQgwsCSAioFiFCksVhjEgA8KLsaqFMWb+GHVv2bNq1qbq2nXt2qwYVxuAFwEOjx58RAIgZLqAIAEMAvgg4odFP0CPnQPRMAgA1EAjXPwbNAWGFxlES8KbpEEKjWv+gd4a/gWtcm+Iu2nVnxX1f/37+/f2Xze8/AaUCo4K3gqJghxMaoCGO1FCjhCVo4rJvjwoaoMQ+ADJgAocKtEDtsCAuaMAMobY4RKMcfqBQCI0uyAy1yqAbJEQAylhsB6AyGJCrHn8EUrYBCggyyACLRDKoKxyRQ4OgIhCDhgpUECoCHmigYTqgVCODQZCEUgHLIYaSg0EfUOMRAGMg2IO9oLppYAkkgtquARvmFMqlOpJM6siqhuSPAD/51G+AAYISlAAAAE2KgQAWIDS2QSPtsQY6hXLiTKKQsFSCCFQDqpE2iiIELqBC1EAISzcUaogaQnzBuAiGMHWoU4ICFTX/DValdCmpDEU0AEUZPcoCrxQgcixBe+0PWKASXTTZowhgwABpmR1rUmz9s/FUobpN00ZUvx2q23LP7VYCUHdECjVzt9XWKGcBgJbYohQwQFEALHiArGW3vW/eegcwIAADICXKggQsMADgbB0e8F0AnGxXKYm93SrNczWcGN5fD31W2EUJNhjhoBB4lKgDFOiqXwAKMIDlABAAagGZLQDKUJYZgFTQBLpKIGevXN63KwMaBsDmrnAeeWeTIR5KYJEHUADSB5AeigEMFkgZaqzi9Zo2iSkWimyOL47KyYvNdspGjbEFmyiph60agKuHSkCBogw49ABrXzaA5gICOMAB/waCXoABmqlW9IF+fU6665oDwADwAwAHwHDEFV9UgcaJDltosIZNluvLhcKAAaAMYDr021xP0kngkpIBKbaPul2o2pXCK3dm444arKlLJ1yoeYPiGmGYXwYZAMVTDyqBoBlFoOF/AQg8aiKRfbZh6IGSPlqgqoc95+brTfYAkYUKf1+kjS25fKWAl58sJ2HirIegNKjAo+GE0kgFBAgUvDSgBySCScdOcqEG4EAoOIBJBU5wgY7h7wI9aEBegCLA/gkAgBrBSQV8Fyn6BWVu4gOA+vQFPr0NRVCnW1YBmmetwX1leski3/Wyh4ABeIVI6yNAw2rolRuOD2uuOyGjuP/mgKyNzm5WA139iFJCKWaFRxRgCAROUAGgGOcE43kRcCjQGQFAwIMhuoAEIdAZvGTgM8n54HBIcMUsbpGC9iljGAlIRgGs4AQUAhgVRxYs0k2OiSeT3OSUJ0SQOYByGGih8XBoPdwETn1BE58BKkcv70XShJOUXxJdxsOhfG91rdtXFKsYFEGucn7CK0EcO4MgPnbgj0E5QV0qgqAX/Q8oFaHLZzbEI88AswNBGQ4ZZ0eXutwSKLlM5uw8FhVRjq95QcGXvgrQL76l8G8wY2ICGOAAwymPSNSjZFACxzVFBZFIecvc3coJlAKcE5TlS2LBAqCAQwblAZgEigVU9yz/BpzOla05qFgmFQEs8lEo0AygGPvHBYaIxjgzSKYAKGCcXmrEOHHJqAcZ2haNzCAuoukMRSsg0eHYEmqCzGdX+EkUB/xMpkRaWcvoqc+6JY2nhQRADitJM5vii0gOkBnBavZTFJIvoVap3tOe2sqnFmVQaarADS4kwrxEgCUNmEECgwKTLAblB1/NKhc3RNYyZjADPFIMCBuAVa32RgAsAsoaPZLBsYLVrgztGNx+JEPatK+qrKFaPw9L1cMiFClinApwrqhByhKQd0KBbBste1DGsoawrxFUVwag2MaKRX1fMWhCO1vauLmLXVt6gWrSxKPYoslbrk3KWy1mnxDx/0hdsmVXbNf1tt+V1rjHrc1qG6tc5O6Huc2Vor1qQ8riQhcqz7WubbArXa1cL3qUTK1RCgBQFxavKN5dHXmRgoGZQeUBMiUtUJCqyqkk8VpTBEtRlNay8B6Fun1aYX+wq9rsCpaa5xteUgrgKKBJ9WVeyR56hfJCpYzXKBQ+b2f/9hSYFU4BqBTKATh3FfsiJQD3HYrhQEaAAQQYKf81sYudW2CnDJjGkvoYIVEor3yNTwE0G8rgwEc4CQerv0SxcIaPTC/GImCc7mWawo6yPBIjeFgkO9gUUTzhRIouAKNkMM6om7cDhNZgwyLig8/cva4kS2cB4JlCbzy/OZMwx/8hu3LBsiwUlDkYybg5sc+AtlMmX+4ryXJADw2GSSfDmWYUNpSeexYAm2JyAEEbogL6+wBUGstaR5SkNzep3y7fmcl0sxqoAXBipDjyx0bhGgYcWTlSkpJh4X1AC9eHMkUt2AHqI1K9PGc3+lbFxq48dp0BZGphpxpvnpyyaxxZAMglD3MYpmcAmOisfzKZZigrc/Go5uxqp+zSQnEA64iitaB02G6qzpkMA3DNooz4T8IDqumWkl+iEEBmAQBxtKbN5yEZoL//Wp/jgqK4BfuziEGFt7GVfZRkT1zO1MQ3CvVtQpChrCtAFoqQASDOcKtTcOBdCgEcqbyg8cvkkCb/XslXtzj1frY1K+QeJ+V1VAXQW3tV1jGjVLiU+yravEExFpF46MOXOYoBSneUtGrKYNes79zxpjLzmhrx2wjP618He9jFPnayl93sX7c4kmBqZRQOPXqeVB/NIKzmfbZzqNcuXgH+TYDrWdjoH4c5UFSoQ5onzabznuIKgdiw/Vo6WS9sfKitUuLIkZbVTzFAAi4Z75Bru3qpS1be7A6UhBON4QO128OdqpWKS7H1af8asxNceT6vL4XtDXKACI/3Azg5WcJSX7tbDuLAA4C9Dtj9ufl2OZsvfNQ91jkCcGZtRr1Q+pEzmb2pUs2g+vzyRuGhvlC2NZG5k8WQSp0D/0gpqMo9AGTvBcrTxycyXwP71Fu/OOxZqX8grT3oo/Q5fAEylAG5dtO9u1ueF/K1B1OULLOZoKEW+XoAvhO3fkGqQ0m+oJG/lfE5Toueo1KqoFi5RXGZ4xlB7AM6PFsUnoov4SGKBTi87Bk5mbKWA1C0HqMuXlsAfYK/oBq0GoK+IGozzoO4/OO/1+O/1zmwoGPBohAoowm4Bysvk+M9pGoZkdlBg7k6j5u3cLsckpk3JspAHzSYniMKJzskK/yyIxoApgFDTTOe1sm6JHwNJCwfO6TD67ox7rqKDTMKpAIo7gLEoBCxAszDZaNDPDzEplDESOFDq2AvQ0QU7ZMuav8BuflaxDrMw0bMRIrrRK04PEozilBUr098mISKuqvgRFP0FVZ0xbBZRdh4L5fhGspxnu8TLwYrqCl6xdyIxV6EjUecuF9kjVmcHFtMxaPoodEKKmhbNaPIgI+CHQ3QANEApGkCRmahPKNwQegixtUwxshBxi9jmZ4KCvZ6Mk8sCiehi7ZKjneEx3iUx3mkx3q0x7ZSDL4KpGzElm20qi1Drm8si3CsxcpxlKD5GWj7GZ/bN7CIpbzogM9YDDO6x4q0yIu8RwbSCIgRSH6sL7aLtPghuhvryLF4L+ExSFZjr6Ozmy+jCh7pnwnoCpk8u5q0yZsMAJksBI2QpurySEf/BMm6uZuRpLGSFAuC7IqUJJJafJqFfEkAwKAAqAI2wMmqtMqwo8n+4Uiye8if5I+/64p8Y8lV47fmMsqtQMpxVDo4KyU4iy+naCiavMq5pMuuoEoQEAC08UpgpDy3YyWAPK6z1Iq0VMpFccngYUYEcMakgA65rMvHrMoJECa93EtXpLwlIsoCE8ysIMxbZLBiW7CuYAAZOwq4qgDIRM3I7KOerEx+5D4YIz3ANK7NdBhiEgDHTM3cJLue2JLW/MmY2qcWLMuABEacmACaPM7kVM7lZM7mdM7nhM7obM4AUIIJwInK8s3sXETadBgs8o4LwcjwFE/xbAArWAy10c70/9xEYESI3oir8YTP+JTHuIKAlaJM9cRPzQTGnrSo/vTP/wTQABXQASVQAS2KdcnPBJ0z7twWUPmo+yQU4wAOvFLQ35RN2LA9O8vGEJFGiOlQCK1Qi/PHogjNefOzyUE9RiRNtctGvEBQ1/GUEP3EER0KgaIZpNpFEmWZFbUqHjUSGQXSIA1GkMQyqYo7EWSAKASAH1MATBIU+OFC6Psy+CIUBhXSK2XFJBJKUEMZxYKnF9S2hmOyUsw10nsAcsq8KsXSNWXT7cs4JWJJkWs3eHM59amcIkM4beK6AbHSNvVT/evLDO1S9tEbo7scGWxSJhNBcfIK0hO/PnWsP5XUSf/luKAjHsU6UvlKUjD9inG6HtFT1FXTpsX8EUil1FO1rtf0ORvNHAXIUaFwOcGjnOtxP6DowctLgAv9D1NF1V41LuCcKSRjsAHwM+1TgAnEjSycUtLTp1L8UV+F1mhNO16V1mq11tmg1mvV1m01Qm711m+FnWwF13ElV3Us13NFVz4R13Rl11Mtu3aF13iV13ml13q113vF13zV133l1371138F2IAV2IEl2II12INFWIEVRikCt4R1WCQCyQuFGdFUUqdovhpb0f36siWr1g4lig712CpxipB9EpE9CpJ9WP+gUVi9PL2ziotV0aJQsWdpMW1Nk9kJWYsaCtbsIgr/wAvW/NmNMgr+tMahkEbJStn/SKIiHQr7I4qThENBE8WgCjMzIxyjcxmYUbTFSTMuc7ApDc6X6bkzK54vc5RghZ+jac2I8KW46B+c8AihwIkQQpAOEoCIQKb67I0bEIq6QggPAgq2jaigeNu4HSsQYgmUTVrd0FJnq734SgCDG6RyW4BZ6z6tG4pYazoiEdMMFcF9MsQvQ1NMk79CW7UBKJxvktw5/EnFIIELIAGhGAg4QqYyAgG1Qg0QeF0S4M1fet3BzYsOgt1jAgrXhV0Q0JAKuI6NrF2NIAG1WlyVfdOY67x6iznCG7h2Y0hA+Sz1MbQV9TevYJr1WR6bo7D1/wmfnAsir0yTBgCBFWiBO8pdMGJeoHDeC4AABFmBC2iBFQABvsqAd9RHAIDb4Wjf943fFZidNXqjOOoj5AXR6H2NQA2wQV0KkBOW3QtN+bO5pRvC7i1bfTHUGmW1XWMK8w1h8AmaxcMv3XThF77JhzSO/ukA/pXddmQIitEAMlqB/EWm+K0ILjKOENCBF1kpAqoAMtKBEKAQGuZfwM0rMLoAHSajIJZglY1YQwoxXIy/6707A3QAEHY8zPVeUW2KNF0fC9AbFP5eFcaeTVrfnwwRnOiAFoBiAqZIwy3eB4YAstGIyzBcCQiBEyhi3hUjCPgMHTiBEJhjurBjKNaA7v8YjwEu4N694v1Q1YS5PMUcOckFFsI7P+MbpwVkJ07iXJAp49IdivCbv8phtcQ5ZSMz45FDSL1xgKHcyzxuAQeuXwBIDkp+5DIKihAg5nbsz3YkZibOq+FoAUqmXft9x0v+SpBsQmGFQluVqcshPBs0GkVRwwMoqm9C5eLxOPWCQQgDMoNZGnpCsDam5VYVrT2V5nlmRc+lCsOi53zuRXt+CjNjRn0G6IAW6IEm6II26ING6IRW6IVm6IZ26IeG6IiW6Imm6Iq26IvG6IzW6I3m6I726I8G6ZAW6ZEm6ZI26ZNGaWUbHNRzlIpNipryCtRN6Zkmi5VeOICjCpZBSIP/oemelgpHGYCzZT62jD+cnopUREefVmqnOMgZXGOivsWA+7djIQqnJMClxmqkQOquOIAh+gqXbrWCUQB8GbWsNuubJpKVXACbLmqwPoqCQQDFdMuzputbXEvVYeuoJoqplqnM7QpIYcq6PutU7KF+yeuWpgrERhl5FmyUPludejCWNmqpWACs5djGTulkxOzNLgvN5uzPBu3QFu3RJu3SrrMaesv16orUVhlHKWu5mVrTJmiY7uujeC+mQe2oWEnWHgqWudB0s0XZFmjgxqRtsm2jzm2o2O2mEBTGfjBSFe5LNhZn/Df5g582q6EawqRbZrqAkqnVNr6kcrCf0dWi/77s6F7cggFMwxGZ2862R6lFmvFtw8SZ6Ta+1W7uMObp3ubnoughSUTvK/ZswbtuVnNvNWOiqAuty0EZ1VHv+9a2HsKZ03IxRzGok/wKkyHvAM/nB0c3R+mXVDzw3I665d7tpIRwNfyK17Zwp9hwDp9n+0Yd8BZx5KbxQONqH1QdR6GZ3e4hZ8Wm/oZtAIfxpCVuekLWRxExVkvI905wVpvvHiKS9zoU1EZHSLFBqXpxpWjxIpdm2t6nod6nVMypEyNxVuNuOEM0RVM0JsIAo/vnYHHuwYFuL1/q+Q7r4Lbzul7y1w4eIN/zQBf0QSf0Qjf0Q0f0RFf0RWf0Rnf0Rx+H9EiX9Emn9Eq39EvH9EzX9E3n9E739E8H9VDH14AAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the relative positions of various hemoglobin mutations when using isoelectric focusing. Major hemoglobins (H, A, F, S, and C) are shown in bold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11108=[""].join("\n");
var outline_f10_54_11108=null;
var title_f10_54_11109="Interferon gamma-1b: Patient drug information";
var content_f10_54_11109=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Interferon gamma-1b: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20308?source=see_link\">",
"     see \"Interferon gamma-1b: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Actimmune&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Actimmune&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to fight infections having to do with chronic granulomatous disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691639",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to slow the progress of osteopetrosis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to interferon gamma-1b,",
"       <i>",
"        E. coli",
"       </i>",
"       -derived proteins, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor. The flu-like side effects of interferon may be stressful to heart patients.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime to help with flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to give closely if you or a family member is giving the shot at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694744",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not shake the solution.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not shake.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part of opened vial not used after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11496 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-B3512DFB86-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11109=[""].join("\n");
var outline_f10_54_11109=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183604\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183605\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027644\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027643\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027648\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027649\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027651\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027646\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027647\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027652\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027653\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20308?source=related_link\">",
"      Interferon gamma-1b: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_54_11110="Assessment of mold in the indoor environment";
var content_f10_54_11110=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of mold in the indoor environment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Robert G Hamilton, PhD, DABMLI, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11110/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/54/11110/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mold is ever present outdoors and it is readily introduced or physically transported into the home, work, and school indoor environments.",
"   </p>",
"   <p>",
"    This topic will focus strictly on the detection of mold in indoor environments. The proven and unproven health effects of indoor molds are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25689?source=see_link\">",
"     \"The role of fungi (molds) in human disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The generic term \"mold\" encompasses many types of fungi, a diverse class of eukaryotic microorganisms that live on organic nutrients. The Kingdom Fungi is comprised of plants without leaves, flowers, or roots that reproduce from spores, and includes yeasts, molds, smuts, and mushrooms (",
"    <a class=\"graphic graphic_table graphicRef50012 \" href=\"UTD.htm?3/24/3468\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Molds lack",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/12/38081?source=see_link\">",
"     chlorophyll",
"    </a>",
"    and vascular tissue. They range in form from a single cell to a body mass of branched filamentous hyphae that spread into and feed off of dead organic matter or living organisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PROPERTIES OF MOLDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molds produce specialized, uniquely structured, fruiting bodies called spores that are generally invisible to the naked eye (",
"    <a class=\"graphic graphic_table graphicRef50012 \" href=\"UTD.htm?3/24/3468\">",
"     table 1",
"    </a>",
"    ). The unique features of these spores are used to speciate the mold by microscopic, immunologic, and molecular biology techniques.",
"   </p>",
"   <p>",
"    The majority of the spores produced by molds range in size from 2 to 20 microns in diameter and 1 to 100 mm in length. These spores can become readily airborne. The spores appear as oblong and irregular biomasses, with visually characteristic shapes, sizes, and colors that can be discriminated from each other microscopically (",
"    <a class=\"graphic graphic_figure graphicRef51714 \" href=\"UTD.htm?22/49/23315\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef65951 \" href=\"UTD.htm?28/62/29666\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef67550 \" href=\"UTD.htm?0/7/116\">",
"     picture 1",
"    </a>",
"    ). Morphologically, the spore surface under a microscope may appear as smooth, granular, warty, spiny, cup-shaped, pie-crust shaped, or reticulate (",
"    <a class=\"graphic graphic_figure graphicRef62506 \" href=\"UTD.htm?27/17/27923\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Mold spores need a relative humidity &gt;65 percent, a temperature between 50 to 90&ordm;F (10 to 32&ordm;C), and organic matter as their nutrient base to grow. When a spore germinates, it produces hyphae or branches that digest organic matter on the growing surface.",
"   </p>",
"   <p>",
"    The general appearance of mold varies widely in texture from a filamentous cottony or granular display to a leathery or smooth velvety surface. Mold can present as colorless or with a white, gray, brown, black, yellow, green, or fluorescent hue (",
"    <a class=\"graphic graphic_picture graphicRef67550 \" href=\"UTD.htm?0/7/116\">",
"     picture 1",
"    </a>",
"    ). As mold grows, it often exudes a \"musty\" odor that results from volatile organic compound vapors which are released.",
"   </p>",
"   <p>",
"    There are approximately 100 indoor molds that have been identified as potentially hazardous to human health, although only a small subset of these are commonly found in the air and dust in indoor environments (",
"    <a class=\"graphic graphic_table graphicRef67631 \" href=\"UTD.htm?6/13/6363\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef61386 \" href=\"UTD.htm?1/22/1387\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The classification of medically-important molds, some that are known to elicit IgE antibodies in humans, is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef61257 \" href=\"UTD.htm?43/15/44284\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DETECTION OF INDOOR MOLD GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is often mold growth where there has been water damage or constant high humidity. Invisible spores can be transported indoors on clothing, shoes, or pets, or they may blow in through open doors, windows, or ventilation systems. Spores can survive on wood, paper, carpet, soil, plants, fabrics, and other surfaces. As they settle on a surface with the right humidity and temperature, mold spores begin to germinate, gradually producing an increasingly expanding network of hyphae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Odors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nose may be the first sensory organ to identify a mold infestation as a result of the pungent organic compounds molds release into the air. Any musty odor raises suspicion that a major mold contamination is present, even if it cannot be readily seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Visual signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;An initial indoor environmental assessment involves a visual inspection of the floor, walls, windows, and air handling system. Mold can sometimes be visually detected as a discolored surface. The environment should also be inspected for sources of dampness or standing water. Visible mold can be remediated without further testing or analysis. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Prevention and remediation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following criteria should be met before professional evaluation of the home and",
"    <span class=\"nowrap\">",
"     work/school",
"    </span>",
"    environment for mold is performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has a confirmed condition known to be related to fungus such as a hypersensitivity disorder (eg, asthma, allergic rhinitis, hypersensitivity pneumonitis, or sinusitis) or a severe fungal infection (especially in an immunocompromised individual). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25689?source=see_link\">",
"       \"The role of fungi (molds) in human disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is evidence of exposure to a specific fungus that is known to cause the condition the patient has (",
"      <a class=\"graphic graphic_table graphicRef61386 \" href=\"UTD.htm?1/22/1387\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Detection of indoor mold growth'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The indoor environments to which the patient is exposed should be evaluated for growth of the implicated species of fungi if these two criteria are met. Sampling and testing are generally not necessary if visual inspection reveals mold. In these cases, laboratory testing does not add value to the decision to remediate the environment, since the mold contaminated surface is visually identifiable. However, further assessment is indicated if no mold is seen, but musty odors suggest mold contamination or there is a known history of water damage in that environment.",
"   </p>",
"   <p>",
"    Mold spore confirmation testing does not provide definitive information for making decisions about remediation, since there are no federal limits for acceptable levels of mold spores in any indoor environment. Dust collection or air sampling together with culture, microscopic evaluation, DNA analysis, and immunoassay do provide alternative approaches to assessing an indoor environment if the visual confirmatory test is equivocal or negative and the nose detects a mold problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ASSESSMENT FOR MOLD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The systematic process of assessing an environment for the presence of mold involves two phases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sampling of the environment",
"     </li>",
"     <li>",
"      Analysis to detect evidence of specific mold(s)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, no single laboratory collection method or analytic test can be used to definitively type and quantify mold in an environment, since molds are continually changing with time.",
"   </p>",
"   <p>",
"    We recommend that the person performing the assessment be a certified industrial hygienist, since this ensures a defined level of training and knowledge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sampling methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of environmental sampling methods are used to assess the burden of mold in an environment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/3\">",
"     3",
"    </a>",
"    ]. The four principal collection techniques include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obtaining a bulk \"reservoir\" dust from the floor or ventilation system",
"     </li>",
"     <li>",
"      Sampling of a piece of the physical surface that is discolored",
"     </li>",
"     <li>",
"      Performing a residual surface swipe on a suspected contaminated surface",
"     </li>",
"     <li>",
"      Obtaining an air sample using one of several multi-stage samplers that are often equipped with a nutrient filled culture plate",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Bulk reservoir dust collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bulk surface \"reservoir\" dust specimen is a sample of accumulated particulate released from the air over time. It can be collected using a vacuum device that is equipped with any of a number of collection unit attachments (eg, nozzle sock) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sampling should be performed where individuals spend the majority of their time in the environment (eg, bedroom, family room, kitchen, study) and where the symptoms are believed to be induced. For practical reasons, the mattress in a bedroom is vacuumed first, followed by upholstered furniture, and then carpeting. The bare floor adjacent to a major item of upholstered furniture is vacuumed if carpet is not present. A global specimen may be taken from the major areas where the individual spends most of their time and where they feel mold contamination is most likely if cost is an issue. However, separate testing of rooms allows more definitive testing of specific areas.",
"   </p>",
"   <p>",
"    The collected material may include associated debris (sand, human and animal hair, textile fibers, lint, human dander, coins, or insect parts). Once collected, the bulk dust is processed by passing it through a 50 mesh metal sieve. This removes irrelevant particulate and allows 300 micron diameter and smaller particles including mold spores &lt;20 microns to pass through.",
"   </p>",
"   <p>",
"    A second form of bulk sampling involves removal of a piece of actual discolored surface material from the wall or floor. Often material from different sites is evaluated. Each is stored in a sterile plastic bag prior to evaluation. These specimens are more problematic to test as they are heterogeneous and there is no reference method for processing them for culture or microscopic analysis.",
"   </p>",
"   <p>",
"    Once in the laboratory, a portion of the sample can be mounted on a silicone grease or petroleum gel-covered slide, stained, and examined microscopically for the presence of characteristically shaped fungal spores. This method provides a measure of the total spore count. It is more difficult to perform with a piece of wall board or carpet on which mold contamination is suspected.",
"   </p>",
"   <p>",
"    A second portion of the bulk dust may be evaluated in a microbiologic assay for viable mold spores. One method involves distributing 5 mg of sieved fine dust from the bulk specimen in a physiologic buffer onto medium in a culture plate that contains antibiotics to prevent bacterial growth. Mold spores, if present and viable, grow into colonies that can be visually enumerated at 24, 48, or 72 hours. Some normative data are available on the number of viable colonies per gram of surface dust in homes across the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Surface wipe sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mold that settles out from air onto various indoor surfaces can be collected using a surface swab or clear adhesive tape transfer technique. Contents on the swab are released into a physiologic buffer (eg, phosphate buffered saline) and delivered onto a culture plate in a manner similar to that used for the bulk dust sample. The adhesive tape contact sample can alternatively be stained and analyzed for spores microscopically. The smoother the surface being sampled, the greater the efficiency of adhesive tape collection. Swab collection techniques are sometimes problematic in that the spores may be damaged during sampling, which compromises viability. Both swab and tape sampling are inexpensive, readily mastered, and non-destructive sampling techniques. However, they are highly variable in terms of their ability to collect reproducible test specimens that produce comparable colony counts upon analysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Sampling of air",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aerosolized spores can be sampled by gravity samplers, inertial impactors, or filtration devices [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/3\">",
"     3",
"    </a>",
"    ]: The suction impactors are generally preferred for mold evaluation, since they have the highest efficiency of mold spore collection and they allow automated monitoring over a multi-day period.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The gravity sampler allows particles to fall on a collecting surface, usually an adhesive-coated glass slide or a culture plate. Gravity generally plays a small part in the collection, because air is never still. The larger the particle size, the more efficient the collection in a gravity sampler.",
"     </li>",
"     <li>",
"      Inertial impactors depend upon particle motion for collection. They either pass airborne particles across a stationary surface using a fan or suction apparatus or they move the collection surface through the air at a constant speed. Collection efficiency of inertial impactors depends upon the particle size, with smaller particles remaining in the air stream and having a lower probability of impacting on the collection surface that is coated with a sticky substance (eg, thin layer of silicon grease). Rotation impactors such as the rotarod, liquid impingers, and suction impactors are included in this group. The rotarod uses a 1.2 mm wide plastic rod with the leading edge that is greased. It is satisfactory for collecting particles down to 10 microns in diameter, which includes some larger mold spores.",
"     </li>",
"     <li>",
"      Suction impactors include slit samplers (eg, Burkard spore trap) that draw measured quantities of air across a narrow slit onto a moving drum over a 24 hour or seven day sampling period. Alternatively, cascade impactors (eg, Andersen sampler) draw air over a large entrance orifice and accelerate it stepwise through plates of increasingly smaller pore or sieve sizes. Increasing the speed causes smaller particles to be trapped more efficiently. These samplers discriminate between particle sizes and are better at trapping small mold spores than the inertial impactors or gravity samplers. Petri dishes filled with media nutrients can also be placed in the Andersen sampler to directly collect viable spores with different particle sizes for culturing and further analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Air sampling methods are unfortunately prone to contamination by collection of molds that may enter the air space, but that are not representative of the molds that have caused the environmental contamination of concern. This can occur as a result of open doors or windows that allow contaminating or irrelevant molds into the air space during the sampling period. In addition, different molds are more or less effectively trapped, depending upon their size and shape. Moreover, air sampling may sometimes be inexact because spores can be in an inactive form at the time they are collected, since biologic activity requires humid, warm, nutrient-filled conditions that may not be present at the time of sampling. These inactive spores are not contributing to mold contamination observed in an environment at the time of sampling, but they can become activated when cultured and will be included in the quantified spore count.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Analysis methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the specimen has been collected, it can be analyzed by bioassay, biochemical assay, culture, direct microscopy, nucleic acid analysis, or immunologic assay to identify and quantify the specific molds in the sample. Only a few of these methods are discussed, since a combination of these are most widely used today to speciate and quantify the mold content of indoor environments where visual inspection has failed to detect a mold infestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Direct Microscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual identification of mold should be performed by a certified technician who is familiar with the morphologic forms of different fungal spores. Direct microscopic examination is used to quantify the total number of fungal spores on a slide. One limitation of this technique is that it quantifies the total fungal spore burden (both viable and inactive spores), since only a percentage of fungal spores that are counted will be viable and therefore contribute to widespread mold contamination of the environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Culture is commonly performed, regardless of the collection method, to expand the spore number so that other laboratory techniques can more readily detect the various molds present. A nutrient medium, with antibiotics such as penicillin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    to prevent bacterial growth, allows growth of viable spores. The individual colonies are then identified macroscopically, microscopically, biochemically, immunologically, or based upon their nucleic acid profile. The number of viable mold spores are then reported at 24 or 48 hours as colony counts per gram of bulk dust or colonies per cubic meters of air sampled.",
"   </p>",
"   <p>",
"    The culture procedure has technical limitations that can lead to underestimates of the actual spore levels for several reasons. Some spores have highly specialized growth conditions that are not mimicked by the contents of the culture plate. Other spores produce inhibitors that can prevent growth. Overcrowding induces soluble inhibition factors and growth of colonies may diminish as a result of contact suppression. The collection process often has a desiccating effect that reduces the viability of some spores. Finally, most spores have limited viability periods when airborne and these time intervals vary among the different spore types and release times during the day.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Nucleic acid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mold-specific, quantitative polymerase chain reaction (PCR) assay is a laboratory tool for assessing the content of mold in extracts and surface dust. One group used a PCR based assay to detect the presence and relative levels in house dust of 26 mold species associated with water damage and 10 mold species not associated with water damage. An Environmental Relative Moldiness Index (ERMI) was developed using the level of these molds. These 36 molds were measured in the dust from 271 homes of children with asthma. The ability of ERMI level to predict the development of respiratory illness (wheeze",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rhinitis) was then compared with a binary classification of homes as either moldy or non-moldy based upon onsite inspection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. The visual onsite home inspection was not predictive of respiratory illness, while the ERMI was able to predict the occurrence of illness in homes containing mold associated with water damage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Immunologic assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monoclonal antibody based immunoenzymometric assays are available to quantify the level of select individual mold allergens in extracts of surface dust or cultures. \"Indicator\" allergen assays for Aspergillus fumigatus (Asp f group 1 [Ribotoxin], Asp f 2 [Fibrinogen binding protein], Asp f 3 [Peroxisomal protein], Asp f 4, and Asp f 6 [Mn superoxide dismutase] allergens) and Alternaria alternata (Alt a group 1 allergen [acidic glycoprotein]) can be performed and are sometimes useful. However, the technique has a serious limitation in that nutrient requirements are not always optimal for efficient growth of Aspergillus fumigatus or Alternaria alternata and expression of their allergenic proteins. Thus, Aspergillus fumigatus or Alternaria alternata may be present in the specimen, but their specific allergenic proteins are not expressed and thus undetectable by immunoassay. For this reason, quantitative immunoassay analysis is not performed as a routine clinical test, but rather is considered a research tool.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PREVENTION AND REMEDIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Academic and federal agencies have developed guidelines for home owners on the issues of mold, moisture, and health in the home [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11110/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Information is also available at the United States Environmental Protection Agency website (",
"    <a class=\"external\" href=\"file://www.epa.gov/mold/moldguide.html\">",
"     www.epa.gov/mold/moldguide.html",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Reducing humidity by increasing ventilation, covering cold surfaces such as water pipes with insulation, and increasing the air temperature to reduce surface humidity are inexpensive actions that can help discourage mold expansion (",
"    <a class=\"graphic graphic_table graphicRef71099 \" href=\"UTD.htm?1/16/1291\">",
"     table 5",
"    </a>",
"    ). Plumbing leaks and other sources of dampness or standing water should also be fixed.",
"   </p>",
"   <p>",
"    Visible mold can be remediated using several simple measures (",
"    <a class=\"graphic graphic_table graphicRef71099 \" href=\"UTD.htm?1/16/1291\">",
"     table 5",
"    </a>",
"    ). The least expensive and most effective means of removing surface mold involves scrubbing contaminated non-porous hard surfaces with detergent and water, and then drying the area completely. Disinfectants or biocides, such as a chlorine bleach solution, are not usually necessary. Any contaminated areas in which mold has embedded itself, such as a porous wall, floor, carpet, or upholstered area, need to be removed or replaced. A certified industrial hygienist is preferred if professional remediation is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Every indoor environment has some mold present and moisture control is the key to mold growth control. Mold spores need a relative humidity &gt;65 percent, a temperature between 50 to 90&ordm;F (10 to 32&ordm;C), and organic matter as their nutrient base to grow. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Properties of molds'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial inspection for indoor mold includes examination for musty odors and visible mold on surfaces. Visible mold can be remediated without further testing or analysis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Detection of indoor mold growth'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no federal limits for acceptable levels of mold spores in any indoor environment. Thus, mold spore confirmation testing does not provide definitive information for decisions about remediation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Indications for assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A professional assessment for mold in the indoor environment is not indicated unless a patient has a confirmed condition known to be related to fungus and there is evidence of exposure to the specific fungus that causes that condition. The indoor environments to which the patient is exposed should be evaluated for growth of the implicated species of fungi if these two criteria are met. Sampling and testing is generally not necessary if visual inspection reveals mold. However, further assessment is indicated if no mold is seen on visual inspection, but a musty odor suggests mold contamination. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Indications for assessment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Assessment for mold'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures that can be taken to discourage mold growth in the indoor environment include reducing humidity by increasing ventilation, covering cold surfaces such as water pipes with insulation, and increasing the air temperature. Washing non-porous surfaces with detergent and water, and drying the area, effectively address surface mold contamination. Contaminated porous surface areas in which the mold is embedded must be removed. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Prevention and remediation'",
"      </a>",
"      above.) (",
"      <a class=\"graphic graphic_table graphicRef71099 \" href=\"UTD.htm?1/16/1291\">",
"       table 5",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/1\">",
"      Wood RA, Eggleston PA, Lind P, et al. Antigenic analysis of household dust samples. Am Rev Respir Dis 1988; 137:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/2\">",
"      Ergin C, Kaleli I, Mete E, Sim��ek C. [Evaluation of airborne molds in Laodikeia's recreation work environment during an excavation period]. Mikrobiyol Bul 2009; 43:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/3\">",
"      Burge HA, Solomon WR. Sampling and analysis of biological aerosols. Atmospheric Environment 1987; 21:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/4\">",
"      Hamilton RG. Assessment of indoor allergen exposure. Curr Allergy Asthma Rep 2005; 5:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/5\">",
"      Vesper S, McKinstry C, Ashley P, et al. Quantitative PCR analysis of molds in the dust from homes of asthmatic children in North Carolina. J Environ Monit 2007; 9:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/6\">",
"      Vesper SJ, McKinstry C, Haugland RA, et al. Relative moldiness index as predictor of childhood respiratory illness. J Expo Sci Environ Epidemiol 2007; 17:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11110/abstract/7\">",
"      Hamilton RG, Chapman MD, Platts-Mills TAE, Adkinson NF. House dust aeroallergen measurements in clinical practice: A guide to allergen free home and work environments. Immunol Allergy Pract 1992; 14:96.",
"     </a>",
"    </li>",
"    <li>",
"     US-EPA. A brief guide to mold, moisture and your home, EPA 402-K-02-003, July 2002.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5544 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-2B8F6805EC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11110=[""].join("\n");
var outline_f10_54_11110=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PROPERTIES OF MOLDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DETECTION OF INDOOR MOLD GROWTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Odors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Visual signs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INDICATIONS FOR ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ASSESSMENT FOR MOLD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sampling methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Bulk reservoir dust collection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Surface wipe sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Sampling of air",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Analysis methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Direct Microscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Nucleic acid analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Immunologic assays",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PREVENTION AND REMEDIATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5544\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5544|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/49/23315\" title=\"figure 1\">",
"      Spore shapes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/62/29666\" title=\"figure 2\">",
"      Other spore characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/17/27923\" title=\"figure 3\">",
"      Spore surfaces",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5544|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/7/116\" title=\"picture 1\">",
"      Mold spores",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5544|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/24/3468\" title=\"table 1\">",
"      Fungi terminology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/13/6363\" title=\"table 2\">",
"      Indoor fungi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/22/1387\" title=\"table 3\">",
"      Fungi health effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/15/44284\" title=\"table 4\">",
"      IgE-inducing molds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/16/1291\" title=\"table 5\">",
"      Fungi remediation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/5/25689?source=related_link\">",
"      The role of fungi (molds) in human disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_54_11111="Fluvastatin: Pediatric drug information";
var content_f10_54_11111=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fluvastatin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8264?source=see_link\">",
"    see \"Fluvastatin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?36/7/36980?source=see_link\">",
"    see \"Fluvastatin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F16054979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      HMG-CoA Reductase Inhibitors and Risk of Increased Blood Glucose Concentrations and Diabetes",
"     </span>",
"     <span class=\"collapsible-date\">",
"      January 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Health Canada has notified healthcare professionals of updates to the product monographs of HMG-CoA reductase inhibitors (aka, &ldquo;statins&rdquo;) marketed in Canada regarding the risk of increased blood glucose concentrations and a small increased risk of diabetes mellitus following administration of these agents. The risk appears to be greatest in patients already at risk for diabetes (eg, patients with increased blood glucose concentration, hypertriglyceridemia, obesity, hypertension).  However, Health Canada continues to acknowledge that the benefits of statin therapy far outweigh the risk of dysglycemia. It is recommended that clinicians carefully monitor the use of statins in patients at high risk of developing diabetes mellitus.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For additional information, please refer to file://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/16949a-eng.php.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F173506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lescol&reg;;",
"     </li>",
"     <li>",
"      Lescol&reg; XL",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F173507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Lescol&reg;;",
"     </li>",
"     <li>",
"      Lescol&reg; XL;",
"     </li>",
"     <li>",
"      Teva-Fluvastatin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1014860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antilipemic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       HMG-CoA Reductase Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1014895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8264?source=see_link\">",
"      see \"Fluvastatin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children and Adolescents:",
"     <b>",
"      Hyperlipidemia or heterozygous  familial and nonfamilial hypercholesterolemia: Note:",
"     </b>",
"     Begin treatment if after adequate trial of diet the following are present: LDL-C &ge;190 mg/dL or LDL-C remains &ge;160 mg/dL and positive family history of premature cardiovascular disease or meets NCEP classification (NHLBI, 2011). Therapy may be considered for children 8-9 years of age meeting the above criteria or for children with diabetes mellitus and LDL-C &ge;130 mg/dL (Daniels, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children and Adolescents (10-16 years): Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Immediate release capsule: Initial: 20 mg once daily; may titrate dose or frequency (twice daily dosing) at  6-week intervals; maximum dose: 40 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Extended release tablet: Should not be used to initiate therapy; may convert patient if total daily dose is 80 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"     <b>",
"      Dyslipidemia or delay in progression of CAD:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Patients requiring &ge;25% decrease in LDL-C: 40 mg capsule once daily in the evening, 80 mg extended release tablet once daily (anytime), or 40 mg capsule twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Patients requiring &lt;25% decrease in LDL-C: Initial: 20 mg capsule once daily in the evening; may increase based on tolerability and response to a maximum daily dose: 80 mg/",
"     <b>",
"      day",
"     </b>",
"     , given in 2 divided doses (immediate release capsule) or as a single daily dose (extended release tablet)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment for fluvastatin with concomitant medications:",
"     </b>",
"     Children, Adolescents, and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cyclosporine, fluconazole: Do not exceed 20 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Mild to moderate renal impairment: No dosage adjustment needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Severe renal impairment: Use with caution (doses &gt;40 mg/day have not been studied).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     There are no dosage adjustments provided in the manufacturer labeling; systemic exposure may be increased in patients with liver disease; use is contraindicated in patients with active liver disease or unexplained transaminase elevations.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F173480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lescol&reg;: 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lescol&reg; XL: 80 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F173465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Capsules",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1014901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fluvastatin may be taken without regard to meals.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Immediate release capsules:  Do not open capsules; do not use two 40 mg capsules for an 80 mg once daily dose; extended release formulation should be used.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Extended release tablet: Do not break, chew, or crush; swallow whole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1014884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F), excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light; dispense in a tightly closed container.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1014861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct to dietary therapy to reduce elevated total-C, LDL-C, and apo-B levels in patients with heterozygous familial hypercholesterolemia (HFH) and if LDC-C remains &ge;190 mg/dL or if &ge;160 mg/dL with family history of premature cardiovascular disease or presence of &ge;2 cardiovascular risk factors [FDA approved in ages 10-16 years (girls &ge;1 year postmenarche)]. Adjunct to dietary therapy to reduce elevated total cholesterol (total-C), LDL-C, triglyceride, and apolipoprotein B (apo-B) levels and to increase HDL-C in primary hypercholesterolemia, and mixed dyslipidemia (Fredrickson types IIa and IIb) (FDA approved in adults); to slow the progression of coronary atherosclerosis in patients with coronary heart disease (FDA approved in adults); to reduce risk of coronary revascularization procedures in patients with coronary heart disease (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F173556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Fluvastatin may be confused with fluoxetine, nystatin, pitavastatin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F173554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As reported with fluvastatin capsules; in general, adverse reactions reported with fluvastatin extended release tablet were similar, but the incidence was less.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Central nervous system: Fatigue, headache, insomnia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening (including additional class-related events - not necessarily reported with fluvastatin therapy): Alopecia, amnesia (reversible), anaphylaxis, angioedema, arthralgia, arthritis, blood glucose increased, cataracts, cholestatic jaundice, cirrhosis, cognitive impairment (reversible), confusion (reversible), CPK increased (&gt;10x normal), depression, dermatomyositis, dyspnea, eosinophilia, erectile dysfunction, erythema multiforme, ESR increased, facial paresis, fatty liver, fever, fulminant hepatic necrosis, glycosylated hemoglobin (Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     ) increased, gynecomastia, hemolytic anemia, hepatitis, hepatoma, hypersensitivity reaction, immune-mediated necrotizing myopathy (IMNM), impotence, interstitial lung disease, leukopenia, memory disturbance (reversible), memory impairment (reversible), muscle cramps, myopathy, nodules, ophthalmoplegia, pancreatitis, paresthesia, peripheral nerve palsy, peripheral neuropathy, photosensitivity, polymyalgia rheumatica, positive ANA, pruritus, psychic disturbance, purpura, rash, renal failure (secondary to rhabdomyolysis), rhabdomyolysis, skin discoloration, Stevens-Johnson syndrome, systemic lupus erythematosus-like syndrome, taste alteration, thrombocytopenia, thyroid dysfunction, toxic epidermal necrolysis, transaminases increased, tremor, urticaria, vasculitis, vertigo",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1014867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to fluvastatin or any component; active liver disease; unexplained persistent elevations of serum transaminases; pregnancy; breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F7291195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in patients with conditions or on medications that reduce steroidogenesis (eg, ketoconazole, spironolactone, cimetidine). Increases in Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     and fasting blood glucose have been reported with HMG-CoA reductase inhibitors; however, the benefits of statin therapy far outweigh the risk of dysglycemia. Secondary causes of hyperlipidemia should be ruled out prior to therapy; has not been studied in conditions where the major abnormality is elevation of chylomicrons, VLDL, or IDL (hyperlipoproteinemia Types I, III, IV, or V).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Although rare, reversible cognitive impairment (including confusion, forgetfulness, amnesia, and memory loss) can occur with HMG-CoA reductase inhibitors. These cognitive symptoms have been reported at variable times during therapy (1 day to years after initiation) and are reversible with discontinuation; resolution usually occurs within ~3 weeks. Cases have not been associated with fixed or progressive dementia; nor have they been associated with age, specific HMG CoA reductase inhibitor, dose, or concomitant medication use",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1014868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients receiving HMG-CoA reductase inhibitors have developed rhabdomyolysis with or without acute renal failure and/or myopathy; patients should be monitored closely; risk is dose related and is increased with concurrent use of other lipid-lowering medications (eg, fibric acid derivatives or niacin at doses &gt;1 g/day). With concurrent use of cyclosporine and fluconazole; dosage reductions of fluvastatin recommended. Ensure patient is on the lowest effective fluvastatin dose in all circumstances. Discontinue in any patient in which CPK levels are markedly elevated (&gt;10 times ULN) or if myopathy is suspected/diagnosed; monitoring of CPK may be warranted, but may not prevent severe myopathy. The manufacturer recommends temporary discontinuation for elective major surgery, acute medical or surgical conditions, or in any patient experiencing an acute or serious condition predisposing to renal failure (eg, sepsis, hypotension, trauma, uncontrolled seizures). However, based upon current evidence, HMG-CoA reductase inhibitor therapy should be continued in the perioperative period unless risk outweighs cardioprotective benefit. Use caution in patients with renal impairment, inadequately treated hypothyroidism, and those taking other drugs associated with myopathy (eg, colchicine); these patients are predisposed to myopathy. Patients should be instructed to report unexplained muscle pain, tenderness, weakness, or brown urine.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Autoimmune-mediated myopathy (IMNM), has been reported (rarely) with HMG-CoA reductase inhibitor therapy; presents as proximal muscle weakness with elevated CPK levels, which persists despite discontinuation of HMG-CoA reductase inhibitor therapy; additionally, muscle biopsy may show necrotizing myopathy with limited inflammation; immunosuppressive therapy (eg, corticosteroids, azathioprine) may be used for treatment.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Postmarketing reports of fatal and nonfatal hepatic failure are rare; if serious hepatotoxicity with clinical symptoms and/or hyperbilirubinemia or jaundice occurs during treatment, interrupt therapy. If an alternate etiology is not identified, do not restart fluvastatin. Liver enzyme tests should be obtained at baseline and as clinically indicated; routine periodic monitoring of liver enzymes is not necessary. Use with caution in patients with history of heavy alcohol use or a previous history of liver disease; active liver disease and unexplained persistent elevations of serum transaminases are contraindications for use.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F173542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (minor), CYP2D6 (minor), CYP3A4 (minor), SLCO1B1;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C8 (weak), CYP2C9 (moderate), CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F173474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May decrease the metabolism of HMG-CoA Reductase Inhibitors. Management: Dose of HMG-CoA reductase inhibitor may need to be reduced (limit simvastatin adult maximum dose to 20 mg/day, limit lovastatin adult maximum dose to 40 mg/day).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bezafibrate: May enhance the myopathic (rhabdomyolysis) effect of HMG-CoA Reductase Inhibitors. Bezafibrate may increase the serum concentration of HMG-CoA Reductase Inhibitors. More specifically, bezafibrate may increase the serum concentration of fluvastatin Management: Monitor patients closely for myopathy with concomitant use of bezafibrate and HMG-CoA reductase inhibitors. Concomitant use is contraindicated in patients predisposed to myopathy and alternative therapy should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Fluvastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholestyramine Resin: May decrease the serum concentration of Fluvastatin. Management: Administer fluvastatin at least 1 hour or greater (particularly with extended-release form) before, or at least 4 hours after cholestyramine to minimize the risk for any significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: May enhance the myopathic (rhabdomyolysis) effect of HMG-CoA Reductase Inhibitors. Colchicine may increase the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May increase the serum concentration of Fluvastatin. Management: Limit fluvastatin to 20 mg/day in patients who are also receiving cyclosporine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inhibitors (Moderate) may decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May increase the serum concentration of HMG-CoA Reductase Inhibitors. Management: Avoid use of statins metabolized by CYP3A4 (eg, simvastatin) and consider avoiding fluvastatin as well in patients receiving high dose cyproterone (300 mg/day). Consider use of pravastatin, rosuvastatin, or pitavastatin if statin therapy is needed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DAPTOmycin: HMG-CoA Reductase Inhibitors may enhance the adverse/toxic effect of DAPTOmycin. Specifically, the risk of skeletal muscle toxicity may be increased.  Management: Consider temporarily stopping HMG-CoA reductase inhibitor therapy prior to daptomycin.  If used together, regular (i.e., at least weekly) monitoring of CPK concentrations is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: May increase the serum concentration of OATP1B1/SLCO1B1 Substrates. Management: According to eltrombopag prescribing information, consideration of a preventative dose reduction may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of HMG-CoA Reductase Inhibitors. This applies to atorvastatin, lovastatin and simvastatin. Conversely, levels of fluvastatin may be increased. Management: Dose adjustment of the HMG-CoA reductase inhibitor may be warranted. No interaction is expected with rosuvastatin, pravastatin, or pitavastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fenofibrate: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fenofibric Acid: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Fluvastatin. Management: Limit fluvastatin maximum  adult dose to 20 mg/day, and monitor for toxic effects of fluvastatin (e.g., myalgia, rhabdomyolysis, liver function test abnormalities), during concomitant treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors. Specifically, the risk for muscle toxicities, including rhabdomyolysis may be significantly increased. Management: Avoid concurrent use of HMG-CoA reductase inhibitors (statins) with fusidic acid if possible.  If treatment with fusidic acid is necessary, consider temporarily stopping the statin.  With any concurrent use monitor patients closely for statin toxicity.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gemfibrozil: May enhance the myopathic (rhabdomyolysis) effect of Fluvastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: HMG-CoA Reductase Inhibitors may decrease the serum concentration of Lanthanum.  Management: Administer HMG-CoA reductase inhibitors at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of Fluvastatin. Management: Use fluvastatin at the lowest recommended dose, and monitor closely for adverse effects (including myopathy), during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Niacin: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors. Management: This is of greatest concern with niacin doses of 1 g or greater daily.  Avoid simvastatin 80 mg in combination with niacin 1 g or greater in Chinese patients. Canadian labeling contraindicates use of niacin with rosuvastatin 40 mg.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Niacinamide: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pazopanib: HMG-CoA Reductase Inhibitors may enhance the hepatotoxic effect of Pazopanib. Specifically, the risk for increased serum transaminase concentrations may be increased.  Management: Simvastatin is specifically implicated in this interaction.  There is a lack of data regarding the risk with other statins, but caution appears warranted with any statins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Red Yeast Rice: May enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of HMG-CoA Reductase Inhibitors. Management: Consider use of noninteracting antilipemic agents (note: pitavastatin concentrations may increase with rifamycin treatment).  Monitor for altered HMG-CoA reductase inhibitor effects. Rifabutin and fluvastatin, or possibly pravastatin, may pose lower risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Fluvastatin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trabectedin: HMG-CoA Reductase Inhibitors may enhance the myopathic (rhabdomyolysis) effect of Trabectedin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): HMG-CoA Reductase Inhibitors may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1014882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food decreases the maximum concentration (50%) and extent of absorption (11%), but does not decrease efficacy.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F173476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F173490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cholesterol biosynthesis may be important in fetal development. Contraindicated in pregnancy. Administer to women of childbearing potential only when conception is highly unlikely and patients have been informed of potential hazards.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1014903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pediatric  patients: Baseline: ALT, AST, and creatine phosphokinase levels (CPK); fasting lipid panel (FLP) and repeat ALT and AST should be checked after 4 weeks of therapy; if no myopathy symptoms or laboratory abnormalities, then monitor FLP, ALT, and AST every 3-4 months during the first year and then every 6 months thereafter (NHLBI, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Baseline CPK (recheck CPK in any patient with symptoms suggestive of myopathy; discontinue therapy if markedly elevated); baseline liver function tests (LFTs) and repeat when clinically indicated thereafter. Patients with elevated transaminase levels should have a second (confirmatory) test and frequent monitoring until values normalize; discontinue if increase in ALT/AST is persistently &gt;3 times ULN (NCEP, 2002).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Lipid panel (total cholesterol, HDL, LDL, triglycerides):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     ATP III recommendations (NCEP, 2002): Baseline; 6-8 weeks after initiation of drug therapy; if dose increased, then at 6-8 weeks until final dose determined. Once treatment goal achieved, follow-up intervals may be reduced to every 4-6 months. Lipid panel should be assessed at least annually, and preferably at each clinic visit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Manufacturer's recommendation: Analyze lipid panel at initiation and 4 weeks after each titration",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1014886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts as a selective, competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the rate-limiting step in cholesterol biosynthesis",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F7291270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maximum effect: LDL-C reduction: Achieved within 4 weeks",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1014888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Adults: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.35 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;98%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: To inactive and active metabolites (oxidative metabolism via CYP2C9 [75%], 2C8 [&sim;5%], and 3A4 [&sim;20%] isoenzymes); active forms do not circulate systemically; extensive (saturable) first-pass hepatic extraction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Absolute: Capsule: 24%; Extended release tablet: 29%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Capsule: &lt;3 hours; Extended release tablet: 9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Capsule: 1 hour; Extended release tablet: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Feces (90%); urine (5%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1014907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/7/36980?source=see_link\">",
"      see \"Fluvastatin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May rarely cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid exposure to sunlight and artificial light sources (sunlamps, tanning booth/bed); wear protective clothing, wide-brimmed hats, sunglasses, and lip sunscreen (SPF &ge;15); use a sunscreen [broad-spectrum sunscreen or physical sunscreen (preferred) or sunblock with SPF &ge;15]; contact physician if reaction occurs. Report severe and unresolved gastric upset, any vision changes, muscle pain and weakness, changes in color of urine or stool, yellowing of skin or eyes, and any unusual bruising. Female patients of childbearing age must be counseled to use two effective forms of contraception simultaneously, unless absolute abstinence is the chosen method; this drug may cause severe fetal defects. This drug does not eliminate the need for prescribed diet or exercise regimen.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Daniels SR, Greer FR, and Committee on Nutrition, \"Lipid Screening and Cardiovascular Health in Childhood,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008, 122(1):198-208.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/54/11111/abstract-text/18596007/pubmed\" id=\"18596007\" target=\"_blank\">",
"        18596007",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2001, 285(19):2486-97.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/54/11111/abstract-text/11368702/pubmed\" id=\"11368702\" target=\"_blank\">",
"        11368702",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McCrindle BW, Urbina EM, Dennison BA, et al, \"Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 115(14):1948-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/54/11111/abstract-text/17377073/pubmed\" id=\"17377073\" target=\"_blank\">",
"        17377073",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute, \"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents,\" Clinical Practice Guidelines, 2011, National Institutes of Health. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf%20\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van der Graaf A, Nierman MC, Firth JC, et al, \"Efficacy and Safety of Fluvastatin in Children and Adolescents With Heterozygous Familial Hypercholesterolaemia,\"",
"      <i>",
"       Acta Paediatr",
"      </i>",
"      , 2006, 95(11):1461-6",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/54/11111/abstract-text/17062478/pubmed\" id=\"17062478\" target=\"_blank\">",
"        17062478",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13044 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-EBC78AF0D7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11111=[""].join("\n");
var outline_f10_54_11111=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16054979\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173506\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173507\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014860\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014895\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173480\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173465\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014901\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014884\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014861\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173556\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173554\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014867\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7291195\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014868\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173542\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173474\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014882\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173476\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173490\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014903\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014886\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7291270\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014888\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1014907\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13044\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13044|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8264?source=related_link\">",
"      Fluvastatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/7/36980?source=related_link\">",
"      Fluvastatin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_54_11112="Two incision leg fasciotomy";
var content_f10_54_11112=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F70951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F70951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Two incision leg fasciotomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 703px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The medial and lateral incisions are depicted. Arrows represent the subcutaneous flaps that will be developed to gain access to the respective compartments. The four compartments to be decompressed are outlined in color. The approximate location for the fascial incision for each compartment is represented by a black line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11112=[""].join("\n");
var outline_f10_54_11112=null;
var title_f10_54_11113="Five-year relative survival ratio in MM";
var content_f10_54_11113=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Five-year relative survival ratios for patients with multiple myeloma in Sweden from 1973 to 2003",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 645px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Kristinsson SY, Landgren O, Dickman PW, et al. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 2007; 25:1993. Reprinted with permission. Copyright &copy; 2007 American Society of Clinical Oncology. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11113=[""].join("\n");
var outline_f10_54_11113=null;
var title_f10_54_11114="Causes of male infertility";
var content_f10_54_11114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of male infertility",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Ronald S Swerdloff, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Christina Wang, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Peter J Snyder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Alvin M Matsumoto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/54/11114/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/54/11114/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fertility rate in a couple is influenced by several factors. These include: the age of the female partner, age of the male partner, exposure to sexually transmitted disease and to environmental and medical toxins, coexistent disease states, and the specific disorders described below.",
"   </p>",
"   <p>",
"    While many men with male infertility have oligozoospermia (decrease in number of sperm cells in the ejaculate compared to reference ranges) or azoospermia (no sperm cells in the ejaculate), some infertile men have normal sperm counts. Over 80 percent of men with infertility have low sperm concentrations associated with a decrease in sperm motility (asthenozoospermia) and spermatozoa with normal morphology. Others may have a decrease in sperm motility and abnormal sperm morphology (teratozoospermia).",
"   </p>",
"   <p>",
"    The causes of male infertility will be reviewed here, with the exception of unexplained infertility. The evaluation and treatment of male infertility and issues related to unexplained infertility are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33481?source=see_link\">",
"     \"Evaluation of male infertility\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=see_link\">",
"     \"Treatment of male infertility\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25496?source=see_link\">",
"     \"Unexplained infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TRENDS IN MALE INFERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of declining sperm counts and increasing incidence of urogenital abnormalities and testicular cancer in some regions of the world have stirred public interest and concern [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Whether there is deterioration of semen quality is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. Later data in fertile men in Europe and the United States show marked differences in sperm concentration between different countries and different regions of the same country [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. The role of environmental pollutants or toxins remains unclear.",
"   </p>",
"   <p>",
"    Epidemiology studies suggest that fertility rates are lower in men over age 40 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], but results from assisted reproduction techniques have not confirmed this observation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION OF INFERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infertility in a couple is defined as the inability to achieve conception despite one year of frequent unprotected intercourse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17287?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of infertility\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The distribution of male and female causes of infertility has not been well defined. In a 1982 to 1985 World Health Organization multicenter study, 20 percent of cases were attributed to male factors, 38 percent were attributed to female factors, 27 percent had causal factors identified in both partners, and 15 percent could not be satisfactorily attributed to either partner [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causes of male infertility can be divided into four main areas (",
"    <a class=\"graphic graphic_table graphicRef54356 \" href=\"UTD.htm?11/23/11645\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypothalamic pituitary disease (secondary hypogonadism) &ndash; 1 to 2 percent",
"     </li>",
"     <li>",
"      Testicular disease (primary testicular defects including Y chromosome microdeletions) &ndash; 30 to 40 percent",
"     </li>",
"     <li>",
"      Post-testicular defects (disorders of sperm transport) &ndash; 10 to 20 percent",
"     </li>",
"     <li>",
"      Idiopathic &ndash; 40 to 50 percent",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Idiopathic infertility should be distinguished from unexplained infertility, which refers to couples where no apparent cause can be found and the male has normal semen analyses.",
"   </p>",
"   <p>",
"    The noted frequencies represent an estimate of the approximate proportion of men in each category presenting to a tertiary referral center with capabilities to diagnose subtle defects of Y chromosome microdeletion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12824?source=see_link\">",
"     \"Clinical features and diagnosis of male hypogonadism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HYPOTHALAMIC-PITUITARY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any hypothalamic or pituitary disease can cause gonadotropin-releasing hormone (GnRH) or gonadotropin deficiency (hypogonadotropic hypogonadism) and therefore infertility. These conditions can be subdivided into congenital, acquired, or systemic disorders. It is important to diagnose secondary hypogonadism as there are specific therapies available (pulsatile GnRH or gonadotropins). All of these disorders are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8488?source=see_link\">",
"     \"Causes of secondary hypogonadism in males\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2170?source=see_link\">",
"     \"Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=see_link\">",
"     \"Clinical manifestations of hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Congenital disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital idiopathic hypogonadotropic hypogonadism is characterized by isolated gonadotropin deficiency resulting in eunuchoidism (sexual infantilism and eunuchoidal body habitus) and sometimes impaired olfactory function (anosmia). In addition, many of the men have mid-line facial defects, color blindness, hearing difficulties, renal malformations, and cryptorchidism (Kallmann's syndrome). The underlying cause of the hypogonadism is a defect in gonadotropin-releasing hormone (GnRH) secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/21\">",
"     21",
"    </a>",
"    ]. This disorder is reviewed in detail separately.",
"   </p>",
"   <p>",
"    Some men have gonadotropin subunit mutations causing hypogonadotropic hypogonadism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8488?source=see_link\">",
"     \"Causes of secondary hypogonadism in males\"",
"    </a>",
"    .) In studies of a population of Estonian men, a single nucleotide polymorphism in the FSH beta gene promoter was associated with serum FSH concentrations and reproductive parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Men with the T allele had smaller testis volume, lower sperm concentration, and lower serum FSH levels. It is possible that they would respond well to exogenous FSH therapy.",
"   </p>",
"   <p>",
"    Other genetic disorders of gonadotropin secretion include multiorgan genetic syndromes such as the Laurence-Moon-Biedl syndrome, Prader-Willi syndrome, Lowe oculocerebral syndrome, and familial cerebellar ataxia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Acquired diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any hypothalamic or pituitary disease can cause hypogonadotropic hypogonadism and therefore infertility. This can be induced by destruction of GnRH neurons or of the gonadotrophs in the pituitary by interrupting the hypothalamic-pituitary portal circulation or by functional inhibition of GnRH or gonadotropin secretion (",
"    <a class=\"graphic graphic_table graphicRef54356 \" href=\"UTD.htm?11/23/11645\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/26\">",
"     26",
"    </a>",
"    ]. Examples include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pituitary macroadenomas (macroprolactinomas and nonfunctioning adenomas) or surgical therapy of macroadenomas or craniopharyngiomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Infiltrative diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis, histiocytosis, tuberculosis, fungal infections, transfusion siderosis, and hemochromatosis, a genetic disorder of mucosal iron transport that results in increased deposition of iron in many tissues including the pituitary gland [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/27\">",
"     27",
"    </a>",
"    ]. Hemochromatosis-associated hypogonadotropic hypogonadism is nearly always of postpubertal onset. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9833?source=see_link\">",
"     \"Causes of hypopituitarism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=see_link\">",
"     \"Clinical manifestations of hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Vascular lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pituitary infarction and carotid aneurysm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hormonal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional hypogonadotropic hypogonadism and infertility can be induced by hyperprolactinemia, estrogen excess [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/28\">",
"     28",
"    </a>",
"    ], glucocorticoid excess [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/29\">",
"     29",
"    </a>",
"    ], and androgen excess [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/26,30-34\">",
"     26,30-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      While any cause of hyperprolactinemia (drugs, hypothyroidism) may be incriminated, most men have prolactinomas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link\">",
"       \"Causes of hyperprolactinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Estrogen excess may be due to estrogen therapy or to estrogen production by a testicular tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/28,34\">",
"       28,34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic glucocorticoid therapy in men results in lower serum testosterone concentrations and inappropriately normal serum gonadotropins, suggesting an alteration of hypothalamic GnRH secretion [",
"      <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H605726841\">",
"    <span class=\"h4\">",
"     Androgens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen excess may be due to the administration of either exogenous testosterone or other anabolic steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/30-32\">",
"     30-32",
"    </a>",
"    ], androgen overproduction due to congenital adrenal hyperplasia, or tumors of the testis or adrenal glands [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Anabolic steroid use should be suspected in men with low sperm counts, low serum LH concentrations, and a well-androgenized phenotype. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21050?source=see_link\">",
"     \"Use of androgens and other hormones to enhance athletic performance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioid-like or other central nervous system-activating drugs, including many psychotropic drugs, can inhibit GnRH or gonadotropin secretion, resulting in secondary hypogonadism and infertility. GnRH analogues (agonists and antagonists) usually are given to suppress gonadotropin secretion, as in men with prostatic carcinoma; infertility is an expected effect of treatment with these analogues (",
"    <a class=\"graphic graphic_table graphicRef54356 \" href=\"UTD.htm?11/23/11645\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Systemic illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any serious systemic illness or chronic nutritional deficiency can cause hypogonadotropic hypogonadism [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/36,37\">",
"     36,37",
"    </a>",
"    ], primary hypogonadism, and infertility (see",
"    <a class=\"local\" href=\"#H34\">",
"     'Systemic disorders'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity in men is associated with hypogonadotropic hypogonadism with low serum gonadotropin, total testosterone, and free testosterone concentrations. The obesity-associated decrease in serum sex hormone binding globulin (SHBG) contributes to the low serum total testosterone concentrations.",
"   </p>",
"   <p>",
"    In addition, serum free testosterone concentrations appear to be inversely related to body weight and body mass index (BMI), independent of changes in SHBG [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Other factors contributing to the hypogonadotropic hypogonadism seen with obesity include an increase in estrogens through aromatization in adipose tissue, insulin resistance, metabolic syndrome, diabetes mellitus, and sleep apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/41-44\">",
"     41-44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sperm quality may also be inversely related to BMI [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/41,45,46\">",
"     41,45,46",
"    </a>",
"    ]. In one report, men with a BMI &gt;25",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    had fewer chromatin-intact normal-motile sperm cells per ejaculate [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PRIMARY HYPOGONADISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary gonadal deficiency (hypergonadotropic hypogonadism) is an important cause of azoospermia and oligozoospermia. While multiple specific testicular disorders have been identified, the pathogenic basis for testicular dysfunction is often unknown and may reflect an inherited defect in sperm production or response to a more distant event. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=see_link\">",
"     \"Causes of primary hypogonadism in males\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Congenital or developmental disorders of the testes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital and developmental disorders are found in a substantial proportion of infertile men. These include Klinefelter's syndrome, Y chromosome defects, cryptorchidism, varicoceles, and other less common disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Klinefelter's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most common causes of primary hypogonadism and, therefore, male infertility, is Klinefelter's syndrome, which may occur in up to 1:500 to 700 phenotypic males. It is characterized by sex chromosome aneuploidy with an extra X (XXY) chromosome being the most frequent. These patients often have very small testes and almost always have azoospermia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of primary hypogonadism in males\", section on 'Klinefelter's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Autosomal and X chromosome defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of autosomal and X-linked genes have been identified as regulators of spermatogenesis. Gene mutations that have been associated with possible male infertility include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polymorphisms of DAZL (T54A), an autosomal homolog of the DAZ (deleted in azoospermia) gene [",
"      <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/47-51\">",
"       47-51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Polymorphisms of PRM1-PRM2 (protamines responsible for chromatin compaction), TNP1-TNP2 (transition nuclear protein), and USP26 (de-ubiquitinating enzyme family) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mutations in the SYCP3 gene that regulates the synapse between homologous chromosomes during meiosis has been associated with azoospermia in rare patients [",
"      <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Y chromosome and related defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Y chromosome microdeletions and substitutions are increasingly recognized as genetic causes of azoospermia and severe oligozoospermia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/53\">",
"     53",
"    </a>",
"    ]. Up to 20 percent of infertile men have microdeletions in the long arm of the Y chromosome, many of which map to the Yq11 region of the chromosome, that is named azoospermic factor (AZF). The AZF region of Yq11 contains three regions: AZFa, AZFb, and AZFc. Deletion of the AZFa and AZFb regions results in severe spermatogenesis defects and azoospermia. Testicular biopsies in these men may show germinal cell maturation arrest or Sertoli cell-only syndrome.",
"   </p>",
"   <p>",
"    Deletions of AZFc that cause infertility have a variable phenotype ranging from oligozoospermia to azoospermia, and represent the largest, well-defined recurrent deletions in the human genome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AFZb and AFZc regions contain large sections of duplicate sequences allowing for rearrangements and partial deletions. The",
"    <span class=\"nowrap\">",
"     gr/gr",
"    </span>",
"    deletion removes a large segment of the AFZc gene and represents a significant risk factor for oligozoospermia in some [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/56,57\">",
"     56,57",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/58\">",
"     58",
"    </a>",
"    ], populations.",
"   </p>",
"   <p>",
"    The focus on candidate genes has been on the AFZa region because this region, unlike the AFZb and AFZc, does not have repeat sequences. DDx3Y (the DEAD [Asp-Glu-Ala-Asp] box polypeptide 3, Y-linked gene) and USP9Y are genes located in the AZFa region of the Y chromosome. USP9Y has been considered to be a candidate gene for male infertility, as deletions in the gene have been observed in men with azoospermia or severe oligozoospermia. However, deletions in USP9Y have also been reported in two men with normal fertility (a normospermic male and his father), suggesting that USP9Y does not have an important independent role in spermatogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/59\">",
"     59",
"    </a>",
"    ]. When both USP9Y and DDX3Y are deleted, azoospermia is consistently seen, suggesting either that DDX3Y has a critical role in the regulation of spermatogenesis or that the two adjacent genes are necessary for normal sperm development [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Y chromosome deletions may be detectable not only in men with idiopathic \"oligozoospermia\" or azoospermia, but also in men with identifiable other causes of testicular dysfunction. As an example, in a study of 131 infertile men, Y chromosome deletions were found in 16 of 85 men (19 percent) with idiopathic oligo- or azoospermia, and 3 of 46 men (7 percent) with disorders such as cryptorchidism, varicocele, and obstructive lesions of the vas deferens [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/61\">",
"     61",
"    </a>",
"    ]. Similar results were seen in a second report [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Y chromosome defects are transmissible to male offspring if cases are successfully treated by assisted reproduction methods. Thus, genetic testing and counseling should be done before technologies such as intracytoplasmic sperm injection (ICSI) are considered. In Europe, Australia, and many infertility centers in the United States, tests for Y chromosome deletions are offered to the infertile couple. These tests need to be standardized to ensure the quality of the results so that genetic misdiagnosis can be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33481?source=see_link&amp;anchor=H31#H31\">",
"     \"Evaluation of male infertility\", section on 'Sex chromosome and somatic mutations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Cryptorchidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryptorchidism is failure of descent of the testes into the scrotum during fetal development. The defect may result in the testes being located within the abdomen, inguinal canal, or some ectopic location. Both unilateral and bilateral cryptorchidism are associated with impaired spermatogenesis and an increased risk of testicular tumors, although the absolute risk of the latter is small.",
"   </p>",
"   <p>",
"    The spermatogenic defects in cryptorchidism are probably due to developmental abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/64\">",
"     64",
"    </a>",
"    ]. Testicular descent is androgen-dependent; as a result, cryptorchidism is common in patients with congenital disorders of testosterone secretion or action (eg, Kallmann's syndrome, androgen resistance, and androgen biosynthesis defects) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of germ-cell dysfunction with cryptorchidism is correlated with the duration of suprascrotal location of the testes. Serum FSH concentrations are often high, but serum LH concentrations are usually normal, indicating normal Leydig cell function. Formerly cryptorchid men with low serum inhibin B and high FSH concentrations may be at particularly high risk for infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bilateral cryptorchidism must be distinguished from the functional bilateral castrate syndrome in which the testes are not detectable in the abdomen or other location; the latter condition is not associated with an increased risk of testicular tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The testes are more retractile during the first year of life, so that many very young boys with apparent cryptorchidism actually have testes that are transiently elevated into the inguinal canal due to an overly brisk cremasteric reflex [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/64\">",
"     64",
"    </a>",
"    ]. Boys whose testes are permanently located in the scrotum by the end of the first year of life are not infertile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Testicular cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is evidence of an increased incidence of testicular cancer in men presenting with infertility (even in the absence of a history of cryptorchidism) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. As an example, in one observational study of 3847 men with oligozoospermia (using previously published rather than current WHO criteria for normal semen parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/71\">",
"     71",
"    </a>",
"    ], defined as sperm concentration less than 20",
"    <span class=\"nowrap\">",
"     million/mL",
"    </span>",
"    with concomitant defects in total motility [less than 50 percent]), 10 cases of testicular cancer were seen (8 of 10 with no history of cryptorchidism) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/70\">",
"     70",
"    </a>",
"    ]. When compared with a control population, this represented approximately an 18-fold greater incidence of testicular cancer (standardized incidence ratio 18.3, 95% CI 18.0-18.8). However, this study is limited by the small number of cases, and thus, routine screening for testicular cancer in men who present with infertility is not warranted at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Varicoceles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varicoceles are dilatations of the pampiniform plexus of the spermatic veins in the scrotum. Left-sided varicoceles are 10 times more common than right-sided ones, perhaps because of anatomic variations that lower blood flow in the left spermatic vein [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/72\">",
"     72",
"    </a>",
"    ]. The mechanisms by which a varicocele might cause infertility and the reversibility of infertility after varicocele surgery are controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/73\">",
"     73",
"    </a>",
"    ]. Varicoceles are found in about 10 to 15 percent of normal men and an even higher percentage of infertile men [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/73\">",
"     73",
"    </a>",
"    ]; the former finding has led many clinicians to question whether a varicocele alone can cause infertility. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/51/5942?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of nonacute scrotal pathology in adult men\", section on 'Varicocele'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Defective androgen receptor or synthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with congenital androgen insensitivity due to androgen receptor or postreceptor abnormalities and those with 5-alpha-reductase deficiency are nearly always infertile. Men with partial androgen insensitivity (Reifenstein's syndrome) have varying degrees of ambiguous external genitalia, hypogonadism, and infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/74\">",
"     74",
"    </a>",
"    ]. Mild androgen insensitivity can cause infertility alone [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22616?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of disorders of the androgen receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Normal sexual differentiation and spermatogenesis require androgen and a normal functioning receptor. Polymorphisms of the androgen receptor gene may also be associated with male infertility. The number of trinucleotide (CAG) repeats in exon 1 of the androgen receptor is inversely correlated with the transcriptional activity of the androgen target gene [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/76\">",
"     76",
"    </a>",
"    ]. In a study of normal fertile men, those with short CAG repeats had the highest sperm output [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reports of CAG repeat lengths in men with idiopathic infertility have been inconsistent. In some [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/78-80\">",
"     78-80",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/81\">",
"     81",
"    </a>",
"    ] reports, a modest association of longer CAG repeat length with male infertility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abnormal semen quality has been observed. In a meta-analysis of 33 studies of men with idiopathic infertility and fertile controls, those with infertility had significantly longer CAG repeat lengths than controls [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/82\">",
"     82",
"    </a>",
"    ]. While androgen receptor CAG repeat length may be a valuable tool for epidemiological studies and pharmacogenomic evaluation of efficacy in treatment trials, it is not a practical tool for assessment of individual patients.",
"   </p>",
"   <p>",
"    Men with 5-alpha-reductase deficiency have pseudohermaphroditism but partially virilize at puberty. Infertility in this disorder may be due to mechanical problems associated with the small phallus, severe hypospadias, cryptorchidism, and poor prostatic secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/83\">",
"     83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30423?source=see_link\">",
"     \"Steroid 5-alpha-reductase 2 deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Disorders of the estrogen receptor or estrogen synthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In mice lacking a functional estrogen receptor alpha, fluid absorption is impaired in the efferent tubules, resulting in excess accumulation of fluid in the seminiferous tubules and impaired spermatogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/84\">",
"     84",
"    </a>",
"    ]. In a man with an inactivating mutation of estrogen receptor alpha, sperm count was normal but sperm motility was decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/85\">",
"     85",
"    </a>",
"    ]. Furthermore, aromatase gene knockout older, adult mice are infertile because of impaired spermatogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/86\">",
"     86",
"    </a>",
"    ]. The generation of estrogen receptor beta knockout mice should provide additional information on the effect of estrogen on fertility in men [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polymorphisms of the promoter region (variable TA tandem repeats) of the estrogen receptor gene have been shown to be related to sperm production. Men with higher numbers of TA repeats have lower sperm counts. Other polymorphisms of the estrogen receptor may have different effects in different populations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Inactivating mutation in FSH receptor gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rare cause of male infertility is an inactivating mutation in the FSH receptor gene [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. One report described five men who were homozygous for an inactivating mutation of the FSH receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/88\">",
"     88",
"    </a>",
"    ]. These men had variably low sperm counts and serum inhibin B concentrations and high serum FSH concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Myotonic dystrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myotonic dystrophy is an autosomal disorder with delayed onset (age 30 to 40 years) of impaired motor function, cataracts, premature frontal balding, mild mental retardation, and infertility due to impaired spermatogenesis. Only 20 percent of men with myotonic dystrophy have low serum testosterone concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Acquired disorders of the testes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually all acquired testicular disorders can cause infertility, often without accompanying Leydig-cell dysfunction. These acquired disorders will be reviewed briefly here; they are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=see_link\">",
"     \"Causes of primary hypogonadism in males\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral orchitis, especially mumps, is a well-recognized cause of infertility. Among those with mumps, clinical orchitis is rare in prepubertal males but occurs in 15 to 25 percent of adult men. Some, but perhaps not all, of these men become infertile, due either to germinal cell damage, ischemia, or the immune response to the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. In mumps and other viral causes of orchitis (echovirus and arbovirus), germ cell failure is much more common than androgen deficiency.",
"   </p>",
"   <p>",
"    Other infectious causes of orchitis and infertility include tuberculosis and leprosy; the former may also cause epididymal obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/93\">",
"     93",
"    </a>",
"    ]. Sexually transmitted diseases (STD) such as gonorrhea and chlamydia can also cause orchitis. HIV-infected men may have relative normal semen parameters while others may have low sperm motility and infertility. White blood cells may be present in the semen, especially if the HIV was associated with other STDs such as gonorrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many drugs are associated with impaired spermatogenesis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Leydig cell dysfunction. Among them, the most important are the alkylating drugs (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"     chlorambucil",
"    </a>",
"    ). Antiandrogens (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/2/30758?source=see_link\">",
"     bicalutamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    cause testicular dysfunction by inhibiting testicular androgen production or action [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/96\">",
"     96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ionizing radiation impairs spermatogenesis. Doses as low as 0.015 Gy (15 rads) may transiently suppress spermatogenesis, while doses above 6 Gy (600 rad) usually cause irreversible azoospermia and infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environmental toxins may be an underappreciated cause of infertility. The pesticide dibromochloropropane is a well-known cause, as are lead, cadmium, and mercury [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/98\">",
"     98",
"    </a>",
"    ]. The possibility that chemicals with estrogenic or antiandrogenic activity (\"endocrine disruptors\"), including insecticides and fungicides, may lower sperm counts has attracted much attention lately, although direct proof of an effect in men is lacking [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/6\">",
"     6",
"    </a>",
"    ]. The suspicion of such an effect originated with observations that sperm counts had decreased over the last several decades. However, a meta-analysis suggested that while decreases in sperm counts have occurred on a local basis, there has been no world-wide decline [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the rapid increase in cell phones use around the world, studies have been done to investigate whether cell phone usage has any detrimental effects on sperm parameters. This issue is controversial and definitive data are not yet available [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on cigarette smoking and its possible effect on sperm counts are inconsistent. However, in a meta-analysis of 20 observational studies, men who smoked cigarettes were more likely to have low sperm counts [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possibility that in utero exposure to smoking may have a detrimental effect on sperm count in adulthood was studied in 1770 young, healthy, potential military recruits and the results showed the possibility of a small effect [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/103\">",
"     103",
"    </a>",
"    ]. Exposure to smoking in utero (after adjusting for some confounding factors, eg, the man's present smoking habits, but not others, eg, alcohol intake) was associated with mean sperm concentrations which were 20 percent lower (95% CI 7 to 34 percent) when compared with unexposed men. The fertility implication of this small difference is not known. In a second study, there were no significant differences in mean sperm concentrations in men whose mothers either smoked or did not smoke during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/104\">",
"     104",
"    </a>",
"    ]. However, men whose mothers had smoked &ge;10 cigarettes per day while pregnant were at higher risk of having oligozoospermia (sperm concentration &lt;20 x",
"    <span class=\"nowrap\">",
"     10(6)/mL).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthermia has long been thought to impair spermatogenesis. Prolonged high testicular temperature may explain the infertility associated with spinal cord injuries, varicocele, and chronic sauna and Jacuzzi exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/105\">",
"     105",
"    </a>",
"    ]. Studies in rodents, monkeys, and men have shown that small increases in testicular temperature accelerate germ cell loss through apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/106-109\">",
"     106-109",
"    </a>",
"    ]. Similarly, febrile illness, prolonged sitting during work or truck driving, welding, baking, tight fitting underwear, and laptop use with increased heat to the testes have been proposed to adversely affect male fertility. The data to support these associations are inconsistent and may be a very weak risk factor for infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/110,111\">",
"     110,111",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Antisperm antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some infertile men have antisperm antibodies in serum or semen and both presumably could impair spermatogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/112\">",
"     112",
"    </a>",
"    ]. Presence of sperm agglutination in the semen should trigger the laboratory to test for anti-sperm antibodies. Whether antibodies occur spontaneously or only after some testicular injury is not known. Primary hypogonadism occasionally occurs in men with type 2 autoimmune polyglandular syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Systemic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with debilitating illnesses such as chronic renal insufficiency, cirrhosis, or malnutrition of any cause may have primary as well as secondary hypogonadism [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/36,114-116\">",
"     36,114-116",
"    </a>",
"    ]. Infertility is common in men with sickle cell anemia, presumably due to intratesticular ischemia.",
"   </p>",
"   <p>",
"    Abnormalities in sperm motility and morphology as well as a biochemical picture of androgen resistance (high serum testosterone and high LH concentrations) have been reported in men with celiac disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link\">",
"     \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     DISORDERS OF SPERM TRANSPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epididymis is an important site for sperm maturation and an essential part of the sperm transport system. The vas deferens then transports sperm from the epididymis to the urethra, where they are diluted by secretions from the seminal vesicles and prostate. Abnormalities at any of these sites, particularly the epididymis and vas deferens, can cause infertility. Finally, sperm must be ejaculated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Abnormalities of the epididymis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absence, dysfunction, or obstruction of the epididymis leads to infertility even though testicular sperm production is normal. Intrauterine exposure to estrogens may cause epididymal dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/117\">",
"     117",
"    </a>",
"    ]. Little is known about functional abnormalities of the epididymis, but some drugs used in other countries (eg, triptolide) and chemical toxins (chlorhydrin) affect the function of metabolism of spermatozoa within the epididymis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/118\">",
"     118",
"    </a>",
"    ]. While poorly documented, it is presumed that some men with isolated asthenospermia (impaired motility) have defects of epididymal function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Abnormalities of the vas deferens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Male infertility can result from acquired or congenital abnormalities of the vas deferens. Bilateral obstruction, ligation, or altered peristalsis of the vas deferens results in infertility. Obstruction may result from infection (gonorrhea, chlamydia, tuberculosis), while ligation of the vas deferens (vasectomy) is an intentional, medically-induced cause of infertility. It may be reversible, but some men have an immune response to sperm granulomas that form on the proximal side of the ligation and remain infertile after adequate reanastomosis of the vas [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/119\">",
"     119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One to 2 percent of infertile men have congenital absence of the vas deferens. Most have mutations of the cystic fibrosis transmembrane conductance regulator, CFTR, gene [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/120\">",
"     120",
"    </a>",
"    ]. Many infertile men with mutations of CFTR present with infertility in the absence of many of the other findings (eg, respiratory and pancreatic disease). A primary ciliary dyskinesia is a genetically heterogeneous disease that affects cilia function and structure. The clinical presentations include recurrent sinopulmonary infections, bronchiectasis, situs inversus and male infertility (with asthenozoospermia or oligozoospermia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/121,122\">",
"     121,122",
"    </a>",
"    ]). Genetic mutations of dynein proteins or thioredoxin-nucleoside diphosphate kinase have been implicated to cause primary ciliary dyskinesia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/123,124\">",
"     123,124",
"    </a>",
"    ]. A similar genetic defect may lead to abnormal transport of sperm is Young's syndrome, in which inspissated secretions within the vas and epididymis interfere with transport of sperm, leading to obstructive azoospermia; impaired axonemal structures are sometimes found [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/125,126\">",
"     125,126",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Seminal vesicles and prostate",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not known if abnormal function of the seminal vesicles and prostate contributes to infertility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Defective ejaculation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal cord disease or trauma, sympathectomy, or autonomic disease (eg, diabetes mellitus) all can interfere with normal ejaculation and lead to decreased fertility. Erectile dysfunction, mechanical obstruction (condoms and diaphragm use), premature ejaculation, and infrequency of intercourse also may be contributing factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     IDIOPATHIC MALE INFERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite careful assessment of all possible causal mechanisms, a cause of abnormal sperm number, morphology, or function cannot be identified in a substantial proportion of infertile men [",
"    <a class=\"abstract\" href=\"UTD.htm?10/54/11114/abstract/20\">",
"     20",
"    </a>",
"    ]. There are also men who have repeatedly normal semen analyses but cannot impregnate an apparently normal female partner. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25496?source=see_link\">",
"     \"Unexplained infertility\"",
"    </a>",
"    .)",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=see_link\">",
"       \"Patient information: Infertility in men (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/5/32851?source=see_link\">",
"       \"Patient information: Treatment of male infertility (Beyond the Basics)\"",
"      </a>",
"      )",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of male infertility can be divided into four main areas (",
"    <a class=\"graphic graphic_table graphicRef54356 \" href=\"UTD.htm?11/23/11645\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypothalamic pituitary disease (secondary hypogonadism; 1 to 2 percent). Any hypothalamic or pituitary disease can cause gonadotropin-releasing hormone (GnRH) or gonadotropin deficiency (hypogonadotropic hypogonadism), and therefore infertility. These conditions can be subdivided into congenital, acquired, or systemic disorders. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Hypothalamic-pituitary disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testicular disease (primary testicular defect including Y microdeletions; 30 to 40 percent). Examples include congenital or developmental disorders, disorders of the androgen receptor, Y chromosome defects, and acquired disorders such as infection, drugs, environmental toxins, and smoking. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Primary hypogonadism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Post-testicular defects (disorders of sperm transport; 10 to 20 percent). The epididymis is an important site for sperm maturation and an essential part of the sperm transport system. The vas deferens then transport sperm from the epididymis to the urethra, where they are diluted by secretions from the seminal vesicles and prostate. Abnormalities at any of these sites, particularly the epididymis and vas deferens, can cause infertility. Finally, sperm must be ejaculated. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Disorders of sperm transport'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Idiopathic male infertility (40 to 50 percent). (See",
"      <a class=\"local\" href=\"#H40\">",
"       'Idiopathic male infertility'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/1\">",
"      Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/2\">",
"      Irvine DS. Falling sperm quality. BMJ 1994; 309:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/3\">",
"      Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332:281.",
"     </a>",
"    </li>",
"    <li>",
"     Ministry of Environment and Energy, Denmark. Male reproductive health and environmental chemicals with estrogenic effect. Miljoprojekt no. 290. Copenhagen: Danish Environmental Protection Agency, 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/5\">",
"      Irvine S, Cawood E, Richardson D, et al. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. BMJ 1996; 312:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/6\">",
"      Nordkap L, Joensen UN, Blomberg Jensen M, J&oslash;rgensen N. Regional differences and temporal trends in male reproductive health disorders: semen quality may be a sensitive marker of environmental exposures. Mol Cell Endocrinol 2012; 355:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/7\">",
"      Suominen J, Vierula M. Semen quality of Finnish men. BMJ 1993; 306:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/8\">",
"      Ginsburg J, Okolo S, Prelevic G, Hardiman P. Residence in the London area and sperm density. Lancet 1994; 343:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/9\">",
"      Finch, A, Goluhoff, ET, Olson, JH, et al. Semen analyses in 1283 men from the United States over a 25-year period; no decline in quality. Fertil Steril 1969; 65:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/10\">",
"      Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996; 65:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/11\">",
"      Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. BMJ 1996; 312:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/12\">",
"      J&oslash;rgensen N, Andersen AG, Eustache F, et al. Regional differences in semen quality in Europe. Hum Reprod 2001; 16:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/13\">",
"      J&oslash;rgensen N, Carlsen E, Nermoen I, et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002; 17:2199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/14\">",
"      Swan SH, Brazil C, Drobnis EZ, et al. Geographic differences in semen quality of fertile U.S. males. Environ Health Perspect 2003; 111:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/15\">",
"      de La Rochebrochard E, Thonneau P. Paternal age &gt;or=40 years: an important risk factor for infertility. Am J Obstet Gynecol 2003; 189:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/16\">",
"      De La Rochebrochard E, Thonneau P. Paternal age: are the risks of infecundity and miscarriage higher when the man is aged 40 years or over? Rev Epidemiol Sante Publique 2005; 53 Spec No 2:2S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/17\">",
"      Aboulghar M, Mansour R, Al-Inany H, et al. Paternal age and outcome of intracytoplasmic sperm injection. Reprod Biomed Online 2007; 14:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/18\">",
"      Bellver J, Garrido N, Remoh&iacute; J, et al. Influence of paternal age on assisted reproduction outcome. Reprod Biomed Online 2008; 17:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/19\">",
"      World Health Organization. Towards more objectivity in diagnosis and management of male infertility. Int J Androl 1987; 7(Suppl):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/20\">",
"      de Kretser DM. Male infertility. Lancet 1997; 349:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/21\">",
"      Spratt DI, Carr DB, Merriam GR, et al. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987; 64:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/22\">",
"      Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 2008; 23:2160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/23\">",
"      Grigorova M, Punab M, Poolamets O, et al. Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 2010; 95:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/24\">",
"      Grigorova M, Punab M, Zilaitien�� B, et al. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 2011; 96:E1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/25\">",
"      Castro-Maga&ntilde;a M, Bronsther B, Angulo MA. Genetic forms of male hypogonadism. Urology 1990; 35:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/26\">",
"      Bouchard P, Lagoguey M, Brailly S, Schaison G. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab 1985; 60:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/27\">",
"      Charbonnel B, Chupin M, Le Grand A, Guillon J. Pituitary function in idiopathic haemochromatosis: hormonal study in 36 male patients. Acta Endocrinol (Copenh) 1981; 98:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/28\">",
"      Veldhuis JD, Dufau ML. Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. J Clin Invest 1987; 80:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/29\">",
"      MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/30\">",
"      Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/31\">",
"      Matsumoto AM, Bremner WJ. Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab 1984; 58:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/32\">",
"      Sch&uuml;rmeyer T, Knuth UA, Belkien L, Nieschlag E. Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet 1984; 1:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/33\">",
"      Bonaccorsi AC, Adler I, Figueiredo JG. Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 1987; 47:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/34\">",
"      Freeman DA. Steroid hormone-producing tumors of the adrenal, ovary, and testes. Endocrinol Metab Clin North Am 1991; 20:751.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdloff RS, Steiner B, Callegari C, Bhasin S. GnRH analogues and male contraception. In: Pharmacology, biology, and clinical applications of androgens, Bhasin S, Gabelnick HL, Spieler JM, Swerdloff RS, Wang C (Eds), Wiley-Liss, Inc., New York 1996. p.355.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/36\">",
"      Smith SR, Chhetri MK, Johanson J, et al. The pituitary-gonadal axis in men with protein-calorie malnutrition. J Clin Endocrinol Metab 1975; 41:60.",
"     </a>",
"    </li>",
"    <li>",
"     Handlesman DJ. Testicular dysfunction in systemic diseases. In: Andrology: Male reproductive health, 1st, Nieschlag E, Behre HM (Eds), Springer-Verlag, Berlin 1997. p.227.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/38\">",
"      Allen NE, Appleby PN, Davey GK, Key TJ. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 2002; 13:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/39\">",
"      Gapstur SM, Gann PH, Kopp P, et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 2002; 11:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/40\">",
"      Jensen TK, Andersson AM, J&oslash;rgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004; 82:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/41\">",
"      Hammoud AO, Gibson M, Peterson CM, et al. Obesity and male reproductive potential. J Androl 2006; 27:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/42\">",
"      Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999; 84:3673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/43\">",
"      Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007; 48:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/44\">",
"      Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 2004; 27:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/45\">",
"      Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod 2005; 20:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/46\">",
"      Kort HI, Massey JB, Elsner CW, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006; 27:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/47\">",
"      Teng, YN, Lin, YM, Lin, YH, et al. Association of a single-nucleotide polymorphism of the deleted-in-azoospermia-like gene with susceptibility to spermatogenic failure. J Clin Endocrinol 2002; Metab 2002; 87:5258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/48\">",
"      Teng YN, Lin YM, Sun HF, et al. Association of DAZL haplotypes with spermatogenic failure in infertile men. Fertil Steril 2006; 86:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/49\">",
"      Becherini L, Guarducci E, Degl'Innocenti S, et al. DAZL polymorphisms and susceptibility to spermatogenic failure: an example of remarkable ethnic differences. Int J Androl 2004; 27:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/50\">",
"      Tung JY, Rosen MP, Nelson LM, et al. Variants in Deleted in AZoospermia-Like (DAZL) are correlated with reproductive parameters in men and women. Hum Genet 2006; 118:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/51\">",
"      Tung JY, Rosen MP, Nelson LM, et al. Novel missense mutations of the Deleted-in-AZoospermia-Like (DAZL) gene in infertile women and men. Reprod Biol Endocrinol 2006; 4:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/52\">",
"      Nuti F, Krausz C. Gene polymorphisms/mutations relevant to abnormal spermatogenesis. Reprod Biomed Online 2008; 16:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/53\">",
"      Ferlin A, Arredi B, Speltra E, et al. Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab 2007; 92:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/54\">",
"      Kuroda-Kawaguchi T, Skaletsky H, Brown LG, et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 2001; 29:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/55\">",
"      Krausz C, Degl'Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci 2006; 11:3049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/56\">",
"      Giachini C, Laface I, Guarducci E, et al. Partial AZFc deletions and duplications: clinical correlates in the Italian population. Hum Genet 2008; 124:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/57\">",
"      Krausz C, Giachini C, Xue Y, et al. Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet 2009; 46:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/58\">",
"      Visser L, Westerveld GH, Korver CM, et al. Y chromosome gr/gr deletions are a risk factor for low semen quality. Hum Reprod 2009; 24:2667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/59\">",
"      Luddi A, Margollicci M, Gambera L, et al. Spermatogenesis in a man with complete deletion of USP9Y. N Engl J Med 2009; 360:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/60\">",
"      Tyler-Smith C, Krausz C. The will-o'-the-wisp of genetics--hunting for the azoospermia factor gene. N Engl J Med 2009; 360:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/61\">",
"      Krausz C, Quintana-Murci L, Barbaux S, et al. A high frequency of Y chromosome deletions in males with nonidiopathic infertility. J Clin Endocrinol Metab 1999; 84:3606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/62\">",
"      Foresta C, Moro E, Garolla A, et al. Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocrinol Metab 1999; 84:3660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/63\">",
"      McLachlan RI, Aitken RJ, Cram D, et al. Need for standardization and confirmation of STS deletions on the Y chromosome. Fertil Steril 2008; 90:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/64\">",
"      Rajfer J, Handelsman DJ, Swerdloff RS, et al. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone. N Engl J Med 1986; 314:466.",
"     </a>",
"    </li>",
"    <li>",
"     Rajfer J. Congenital anomalies of the testis. In: Campbell's Urology, 5th, Walsh PH, Gittes RF, Perlmutter AD, et al (Eds), Saunders, Philadelphia 1986. p.1947.",
"    </li>",
"    <li>",
"     Buyse M, Feingold M. Syndromes associated with abnormal external genitalia. In: Genetic mechanisms of sexual development, Vallet HL, Porter IH (Eds), Academic Press, New York 1979. p.425.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/67\">",
"      Lee PA, Coughlin MT, Bellinger MF. Inhibin B: comparison with indexes of fertility among formerly cryptorchid and control men. J Clin Endocrinol Metab 2001; 86:2576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/68\">",
"      Aynsley-Green A, Zachmann M, Illig R, et al. Congenital bilateral anorchia in childhood: a clinical, endocrine and therapeutic evaluation of twenty-one cases. Clin Endocrinol (Oxf) 1976; 5:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/69\">",
"      Tal R, Holland R, Belenky A, et al. Incidental testicular tumors in infertile men. Fertil Steril 2004; 82:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/70\">",
"      Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 2005; 174:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/71\">",
"      Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/72\">",
"      Howards, SS. Varicocele. Infert Reprod Med Clin North Am 1992; 3:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/73\">",
"      Pryor JL, Howards SS. Varicocele. Urol Clin North Am 1987; 14:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/74\">",
"      Griffin JE. Androgen resistance--the clinical and molecular spectrum. N Engl J Med 1992; 326:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/75\">",
"      Aiman J, Griffin JE, Gazak JM, et al. Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med 1979; 300:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/76\">",
"      Gottlieb B, Lombroso R, Beitel LK, Trifiro MA. Molecular pathology of the androgen receptor in male (in)fertility. Reprod Biomed Online 2005; 10:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/77\">",
"      von Eckardstein S, Syska A, Gromoll J, et al. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 2001; 86:2585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/78\">",
"      Wallerand H, R&eacute;my-Martin A, Chabannes E, et al. Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility. Fertil Steril 2001; 76:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/79\">",
"      Casella R, Maduro MR, Misfud A, et al. Androgen receptor gene polyglutamine length is associated with testicular histology in infertile patients. J Urol 2003; 169:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/80\">",
"      Dowsing AT, Yong EL, Clark M, et al. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 1999; 354:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/81\">",
"      Rajpert-De Meyts E, Leffers H, Petersen JH, et al. CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 2002; 359:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/82\">",
"      Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin Endocrinol Metab 2007; 92:4319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/83\">",
"      Johnson L, George FW, Neaves WB, et al. Characterization of the testicular abnormality in 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1986; 63:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/84\">",
"      Hess RA, Bunick D, Lee KH, et al. A role for oestrogens in the male reproductive system. Nature 1997; 390:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/85\">",
"      Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/86\">",
"      Robertson KM, O'Donnell L, Jones ME, et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci U S A 1999; 96:7986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/87\">",
"      Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998; 95:15677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/88\">",
"      Tapanainen JS, Aittom&auml;ki K, Min J, et al. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997; 15:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/89\">",
"      Simoni M, Gromoll J, H&ouml;ppner W, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999; 84:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/90\">",
"      Takeda R, Ueda M. Pituitary-gonadal function in male patients with myotonic dystrophy- serum luteinizing hormone, follicle stimulating hormone and testosterone levels and histological dmaage of the testis. Acta Endocrinol (Copenh) 1977; 84:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/91\">",
"      Adamopoulos DA, Lawrence DM, Vassilopoulos P, et al. Pituitary-testicular interrelationships in mumps orchitis and other viral infections. Br Med J 1978; 1:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/92\">",
"      Beard CM, Benson RC Jr, Kelalis PP, et al. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc 1977; 52:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/93\">",
"      Morley JE, Distiller LA, Sagel J, et al. Hormonal changes associated with testicular atrophy and gynaecomastia in patients with leprosy. Clin Endocrinol (Oxf) 1977; 6:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/94\">",
"      Krieger JN, Coombs RW, Collier AC, et al. Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 1991; 164:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/95\">",
"      Umapathy E. STD/HIV association: effects on semen characteristics. Arch Androl 2005; 51:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/96\">",
"      Carlson HE, Ippoliti AF, Swerdloff RS. Endocrine effects of acute and chronic cimetidine administration. Dig Dis Sci 1981; 26:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/97\">",
"      Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974; 59:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/98\">",
"      Schrag SD, Dixon RL. Occupational exposures associated with male reproductive dysfunction. Annu Rev Pharmacol Toxicol 1985; 25:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/99\">",
"      Becker S, Berhane K. A meta-analysis of 61 sperm count studies revisited. Fertil Steril 1997; 67:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/100\">",
"      Deepinder F, Makker K, Agarwal A. Cell phones and male infertility: dissecting the relationship. Reprod Biomed Online 2007; 15:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/101\">",
"      Agarwal A, Deepinder F, Sharma RK, et al. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil Steril 2008; 89:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/102\">",
"      Vine MF, Margolin BH, Morrison HI, Hulka BS. Cigarette smoking and sperm density: a meta-analysis. Fertil Steril 1994; 61:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/103\">",
"      Jensen TK, J&oslash;rgensen N, Punab M, et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am J Epidemiol 2004; 159:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/104\">",
"      Jensen MS, Mabeck LM, Toft G, et al. Lower sperm counts following prenatal tobacco exposure. Hum Reprod 2005; 20:2559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/105\">",
"      Kandeel FR, Swerdloff RS. Role of temperature in regulation of spermatogenesis and the use of heating as a method for contraception. Fertil Steril 1988; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/106\">",
"      Lue YH, Hikim AP, Swerdloff RS, et al. Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology 1999; 140:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/107\">",
"      Lue YH, Lasley BL, Laughlin LS, et al. Mild testicular hyperthermia induces profound transitional spermatogenic suppression through increased germ cell apoptosis in adult cynomolgus monkeys (Macaca fascicularis). J Androl 2002; 23:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/108\">",
"      Lue Y, Wang C, Liu YX, et al. Transient testicular warming enhances the suppressive effect of testosterone on spermatogenesis in adult cynomolgus monkeys (Macaca fascicularis). J Clin Endocrinol Metab 2006; 91:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/109\">",
"      Wang C, Cui YG, Wang XH, et al. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis. J Clin Endocrinol Metab 2007; 92:3292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/110\">",
"      Thonneau P, Ducot B, Bujan L, et al. Effect of male occupational heat exposure on time to pregnancy. Int J Androl 1997; 20:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/111\">",
"      Wong WY, Zielhuis GA, Thomas CM, et al. New evidence of the influence of exogenous and endogenous factors on sperm count in man. Eur J Obstet Gynecol Reprod Biol 2003; 110:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/112\">",
"      Bronson R, Cooper G, Rosenfeld D. Sperm antibodies: their role in infertility. Fertil Steril 1984; 42:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/113\">",
"      Elder M, Maclaren N, Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease. J Clin Endocrinol Metab 1981; 52:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/114\">",
"      Spratt DI, Bigos ST, Beitins I, et al. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins. J Clin Endocrinol Metab 1992; 75:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/115\">",
"      Handelsman DJ, Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993; 22:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/116\">",
"      Wang, C, Chan, V, Tse, TF, Yeung, RTT. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol 1974; 9:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/117\">",
"      Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 1982; 142:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/118\">",
"      Hikim AP, Lue YH, Wang C, et al. Posttesticular antifertility action of triptolide in the male rat: evidence for severe impairment of cauda epididymal sperm ultrastructure. J Androl 2000; 21:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/119\">",
"      Belker AM, Thomas AJ Jr, Fuchs EF, et al. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol 1991; 145:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/120\">",
"      Patrizio P, Asch RH, Handelin B, Silber SJ. Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum Reprod 1993; 8:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/121\">",
"      Munro NC, Currie DC, Lindsay KS, et al. Fertility in men with primary ciliary dyskinesia presenting with respiratory infection. Thorax 1994; 49:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/122\">",
"      Zariwala MA, Knowles MR, Omran H. Genetic defects in ciliary structure and function. Annu Rev Physiol 2007; 69:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/123\">",
"      Storm van's Gravesande K, Omran H. Primary ciliary dyskinesia: clinical presentation, diagnosis and genetics. Ann Med 2005; 37:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/124\">",
"      Morillas HN, Zariwala M, Knowles MR. Genetic causes of bronchiectasis: primary ciliary dyskinesia. Respiration 2007; 74:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/125\">",
"      Wilton LJ, Teichtahl H, Temple-Smith PD, et al. Young's syndrome (obstructive azoospermia and chronic sinobronchial infection): a quantitative study of axonemal ultrastructure and function. Fertil Steril 1991; 55:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/54/11114/abstract/126\">",
"      Ichioka K, Kohei N, Okubo K, et al. Obstructive azoospermia associated with chronic sinopulmonary infection and situs inversus totalis. Urology 2006; 68:204.e5.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7473 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-4EAA1F1B94-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11114=[""].join("\n");
var outline_f10_54_11114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H42\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TRENDS IN MALE INFERTILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION OF INFERTILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HYPOTHALAMIC-PITUITARY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Congenital disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Acquired diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Infiltrative diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Vascular lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hormonal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H605726841\">",
"      Androgens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Systemic illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PRIMARY HYPOGONADISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Congenital or developmental disorders of the testes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Klinefelter's syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Autosomal and X chromosome defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Y chromosome and related defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Cryptorchidism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Testicular cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Varicoceles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Defective androgen receptor or synthesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Disorders of the estrogen receptor or estrogen synthesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Inactivating mutation in FSH receptor gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Myotonic dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Acquired disorders of the testes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Radiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Smoking",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Antisperm antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Systemic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      DISORDERS OF SPERM TRANSPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Abnormalities of the epididymis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Abnormalities of the vas deferens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Seminal vesicles and prostate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Defective ejaculation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      IDIOPATHIC MALE INFERTILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7473\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7473|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/23/11645\" title=\"table 1\">",
"      Causes of male infertility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=related_link\">",
"      Causes of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9833?source=related_link\">",
"      Causes of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30536?source=related_link\">",
"      Causes of primary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8488?source=related_link\">",
"      Causes of secondary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12824?source=related_link\">",
"      Clinical features and diagnosis of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22616?source=related_link\">",
"      Clinical manifestations and pathogenesis of disorders of the androgen receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=related_link\">",
"      Clinical manifestations of hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2170?source=related_link\">",
"      Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=related_link\">",
"      Effects of cytotoxic agents on gonadal function in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33481?source=related_link\">",
"      Evaluation of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/51/5942?source=related_link\">",
"      Evaluation of nonacute scrotal pathology in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17287?source=related_link\">",
"      Overview of infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=related_link\">",
"      Patient information: Infertility in men (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/5/32851?source=related_link\">",
"      Patient information: Treatment of male infertility (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30423?source=related_link\">",
"      Steroid 5-alpha-reductase 2 deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=related_link\">",
"      Treatment of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/57/25496?source=related_link\">",
"      Unexplained infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21050?source=related_link\">",
"      Use of androgens and other hormones to enhance athletic performance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_54_11115="Contraindications medication abortion";
var content_f10_54_11115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contraindications to medication abortion",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrauterine device in place",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic adrenal failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Concurrent long-term corticosteroid therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemorrhagic disorders or concurrent anticoagulant therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inherited porphyrias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inability to understand the effects of the treatment procedure or to comply with its regimen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of adequate access to medical facilities equipped to provide emergency treatment of incomplete abortion, blood transfusions, and emergency resuscitation during the period from the first visit until discharged by the administering physician",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Guidelines per manufacturer (Danco laboratories).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11115=[""].join("\n");
var outline_f10_54_11115=null;
var title_f10_54_11116="Perinatal HCV transmission";
var content_f10_54_11116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rates of mother-to-infant HCV transmission among different subgroups",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Crude rate % (SD)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Weighted rate % (SD)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anti HCV +",
"       </td>",
"       <td>",
"        5.6 (0.3)",
"       </td>",
"       <td>",
"        1.7 (0.2)",
"       </td>",
"       <td>",
"        63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HCV RNA +",
"       </td>",
"       <td>",
"        8.1 (0.5)",
"       </td>",
"       <td>",
"        4.3 (0.3)",
"       </td>",
"       <td>",
"        53",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV-coinfected",
"       </td>",
"       <td>",
"        22.1 (2.1)",
"       </td>",
"       <td>",
"        19.4 (2.0)",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV-negative",
"       </td>",
"       <td>",
"        4.3 (0.8)",
"       </td>",
"       <td>",
"        3.5 (0.7)",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Injection drug use",
"       </td>",
"       <td>",
"        10.8 (1.9)",
"       </td>",
"       <td>",
"        8.6 (1.7)",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Non-injection drug use",
"       </td>",
"       <td>",
"        4.2 (1.1)",
"       </td>",
"       <td>",
"        3.4 (1.0)",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginal delivery",
"       </td>",
"       <td>",
"        6.7 (0.7)",
"       </td>",
"       <td>",
"        4.3 (0.6)",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cesarean delivery",
"       </td>",
"       <td>",
"        6.8 (1.2)",
"       </td>",
"       <td>",
"        3.0 (0.8)",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breastfed",
"       </td>",
"       <td>",
"        6.0 (1.1)",
"       </td>",
"       <td>",
"        3.7 (0.8)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Not breastfed",
"       </td>",
"       <td>",
"        6.3 (0.8)",
"       </td>",
"       <td>",
"        3.9 (0.7)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Yeung, LTF, King, SM, Roberts, EA. Hepatology 2001; 34:224.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11116=[""].join("\n");
var outline_f10_54_11116=null;
var title_f10_54_11117="Pediatric headache examination";
var content_f10_54_11117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Important aspects of the examination of a child with headache",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Examination feature",
"       </td>",
"       <td class=\"subtitle1\">",
"        Possible significance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        General appearance",
"       </td>",
"       <td class=\"indent1\">",
"        Altered mental status may indicate meningitis, encephalitis, intracranial hemorrhage, elevated intracranial pressure, hypertensive encephalopathy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vital signs",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Hypertension may cause headache or be a response to increased intracranial pressure.",
"         </li>",
"         <li>",
"          Fever suggests infection (most commonly upper respiratory infection) but may occur with intracranial hemorrhage or central nervous system malignancy.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Head circumference",
"       </td>",
"       <td class=\"indent1\">",
"        Macrocephaly may indicate slowly progressive increases in intracranial pressure.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Height and weight trajectories",
"       </td>",
"       <td class=\"indent1\">",
"        Abnormal or altered trajectories may indicate intracranial pathology.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Auscultation of the neck, eyes, and head for bruit",
"       </td>",
"       <td class=\"indent1\">",
"        Bruit may indicate arteriovenous malformation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Palpation of the head and neck",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Localized scalp tenderness may occur in migraine and tension-type headaches.",
"         </li>",
"         <li>",
"          Scalp swelling may indicate head trauma.",
"         </li>",
"         <li>",
"          Sinus tenderness may indicate sinusitis.",
"         </li>",
"         <li>",
"          Temporomandibular joint (TMJ) and/or masseter tenderness suggests TMJ dysfunction.",
"         </li>",
"         <li>",
"          Nuchal rigidity may indicate meningitis.",
"         </li>",
"         <li>",
"          Posterior neck pain may indicate an anatomic abnormality (eg, Chiari malformation).",
"         </li>",
"         <li>",
"          Thyromegaly may indicate thyroid dysfunction.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visual fields",
"       </td>",
"       <td class=\"indent1\">",
"        Visual field abnormalities may indicate increased intracranial pressure and/or a space-occupying lesion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Funduscopy",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Papilledema may indicate increased intracranial pressure.",
"         </li>",
"         <li>",
"          Retinal hemorrhages may indicate increased intracranial pressure or head trauma.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Otoscopy",
"       </td>",
"       <td class=\"indent1\">",
"        May demonstrate otitis media; hemotympanum may indicate trauma.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oropharynx",
"       </td>",
"       <td class=\"indent1\">",
"        Signs of pharyngitis? Dental decay or abscess?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic examination (see text for details)",
"       </td>",
"       <td class=\"indent1\">",
"        Abnormal neurologic examination (particularly mental status, eye movements, papilledema, asymmetry, coordination disturbance, abnormal deep tendon reflexes) may indicate intracranial pathology but also may occur with migraine headache.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin examination",
"       </td>",
"       <td class=\"indent1\">",
"        Signs of neurocutaneous disorders (eg, neurofibromatosis, tuberous sclerosis complex, which are associated with intracranial neoplasms) or trauma (bruises, abrasions, etc).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spine",
"       </td>",
"       <td class=\"indent1\">",
"        Signs of occult spinal dysraphism (eg, midline vascular of pigment changes), which may be associated with structural abnormalities (eg, Chiari malformation).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Great Ormond Street Hospital for Children Clinical Guideline. Headache.",
"        <a href=\"file://www.gosh.nhs.uk/clinical_information/clinical_guidelines/cmg_guideline_00045\" target=\"_blank\">",
"         file://www.gosh.nhs.uk/clinical_information/clinical_guidelines/cmg_guideline_00045",
"        </a>",
"        . Accessed on March 29, 2011.",
"       </li>",
"       <li>",
"        Lewis DW, Koch T. Headache evaluation in children and adolescents: When to worry? When to scan? Pediatr Ann 2010; 39:399.",
"       </li>",
"       <li>",
"        Newton RW. Childhood headache. Arch Dis Child Educ Pract Ed 2008; 93:105.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11117=[""].join("\n");
var outline_f10_54_11117=null;
var title_f10_54_11118="Pravastatin and MACE rates in men versus women CARE trial";
var content_f10_54_11118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Pravastatin is more effective in reducing major adverse cardiac events (MACE) in women than in men",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 275px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the CARE trial of patients with a recent history of myocardial infarction and average lipid levels, women had a greater reduction in coronary events (coronary death, nonfatal infarction, need for revascularization with angioplasty or surgery) with pravastatin, compared to placebo, than men (46 versus 20 percent reduction in men, P = 0.001 for both sexes).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Lewis SJ, Sacks FM, Mitchell JS, et al. for the CARE Investigators, J Am Coll Cardiol 1998; 32:140.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11118=[""].join("\n");
var outline_f10_54_11118=null;
var title_f10_54_11119="Metacarpal neck fracture";
var content_f10_54_11119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metacarpal neck fracture with minimal angulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 309px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This fracture of the neck of the&nbsp;fifth metacarpal is nondisplaced and minimally angulated.&nbsp;A faint radiolucent fracture line can be seen (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Josh Bloom, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_54_11119=[""].join("\n");
var outline_f10_54_11119=null;
